Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Aug 11;23:747. doi: 10.1186/s12885-023-11254-x

Prehabilitation in the lung cancer pathway: a scoping review

Kelly Wade-Mcbane 1,2,, Alex King 2,3, Catherine Urch 2,3, Julian Jeyasingh-Jacob 3, Andrew Milne 4, Clair Le Boutillier 2,5,6
PMCID: PMC10416419  PMID: 37568130

Abstract

Background

Lung cancer is the third most common type of cancer in the UK. Treatment outcomes are poor and UK deaths from lung cancer are higher than any other cancer. Prehabilitation has shown to be an important means of preparing patients both physically and psychologically for cancer treatment. However, little is understood about the context and mechanisms of prehabilitation that can impact physiological and psychological wellbeing.

Our aim was to review and summarise primary research on prehabilitation in the lung cancer pathway using a realist approach.

Methods

A scoping review of empirical primary research was conducted. Five online medical databases from 2016 – February 2023 were searched. All articles reporting on prehabilitation in lung cancer were included in the review. For this review, prehabilitation was defined as either a uni-modal or multi-modal intervention including exercise, nutrition and/or psychosocial support within a home, community or hospital based setting. A realist framework of context, mechanism and outcome was used to assist with the interpretation of findings.

Results

In total, 31 studies were included in the review, of which, three were published study protocols. Over 95% of studies featured an exercise component as part of a prehabilitation programme. Twenty-six of the studies had a surgical focus. Only two studies reported using theory to underpin the design of this complex intervention. There was large heterogeneity across all studies as well as a lack of clinical trials to provide definitive evidence on the programme design, setting, type of intervention, patient criteria, delivery, duration and outcome measures used.

Conclusion

A standardised prehabilitation programme for lung cancer patients does not yet exist. Future lung cancer prehabilitation programmes should take into account patient led values, needs, goals, support structures and beliefs, as these factors can affect the delivery and engagement of interventions. Future research should consider using a conceptual framework to conceptualise the living with and beyond cancer experience to help shape and inform personalised prehabilitation services.

Keywords: Prehabilitation, Exercise, Nutrition, Wellbeing, Surgery, Oncological treatment

Background

Lung cancer is the third most common type of cancer in the UK [1]. Treatment outcomes are poor and UK deaths from lung cancer are higher than any other cancer [2]. Cancer incidence and mortality projections within the UK predict that although mortality rates are likely to increase over the next 10 years, there will also be more people living with and beyond cancer [3].

Prehabilitation has shown to be an important means of preparing patients both physically and psychologically for cancer treatment by mitigating deconditioning associated with cancer treatments between the time of cancer diagnosis and the beginning of acute treatment’ [4, 5].

Prehabilitation within cancer surgery has shown to reduce morbidity and improve health outcomes. For example, an improvement in functional capacity [614] and health reported quality of life (HRQOL) [9, 12, 15, 16] as well as a reduction in post-operative complications [9, 15] and length of hospital stay [9, 13, 15, 17].

Few prehabilitation pathways exist for people who do not have surgery, despite 50–60% of people with cancer in the UK being treated with primary, neo-adjuvant or palliative chemotherapy and/or radiotherapy treatment [18]. Along with the rise in the use of targeted agents and immunotherapy, there is potential to optimise quality of life within the lung cancer population. However, little is understood about the context and mechanisms of prehabilitation that can impact physiological and psychological wellbeing.

Prehabilitation is a complex intervention and it is widely understood that the success of a complex intervention depends on the theory underpinning its design [19], which helps to explain the mechanisms underlying an individual’s behaviour, based on what works for them and their circumstances [2023]. Lung cancer treatment regimes can be prolonged and people may experience a range of toxicities, which could limit their ability to engage in prehabilitation interventions. Prehabilitation programmes should therefore be tailored to the individual to optimise symptom control, treatment tolerance and independence [24, 25].

The aim of this scoping review was to review and summarise primary research on prehabilitation in the lung cancer pathway using a realist approach. Realist approaches focus on the contexts and mechanisms that lead to particular outcomes. This approach enables a detailed exploration of factors likely to influence the success of a complex intervention, such as prehabilitation, thereby helping explain how and why interventions may or may not work [26, 27].

Methods

Scoping reviews are particularly relevant to examine the extent, range and nature of evidence on a certain topic and to identify concepts, theories and knowledge gaps from a heterogeneous body of research [28].

The PRISMA extension for scoping reviews was used for the conduct and reporting of this scoping review [28]. This enabled an examination of the extent, range and nature of the evidence on prehabilitation and lung cancer.

Following the Joanna Briggs Institute (JBI) framework [29], this scoping review addressed the following: 1. Define the review questions 2. Determine the inclusion criteria 3. Search strategy 4. Evidence screening and selection 5. Data extraction 6. Data analysis 7. Presentation of the results.

1. Define the review questions.

Prehabilitation is a complex intervention and it is important to understand what has worked or is perceived to work based on measured or predicted outcomes within the lung cancer pathway. Pre-surgical prehabilitation is often a linear process from baseline to a defined, one-off target (surgery). However, this is not the case for patients receiving oncological treatment where prehabilitation may be delivered immediately prior to, during ± after each treatment session or cycle. Our research questions were:

  • A)

    How does the literature within the field of lung cancer describe the structure of prehabilitation?

  • B)

    How does the literature within the field of lung cancer describe the personalisation of prehabilitation interventions?

  • C)

    What are the actual outcomes for lung cancer patients participating in a prehabilitation programme?

2. Determine the inclusion criteria.

All studies included in this review had to involve lung cancer patients who received a form of prehabilitation within a home, community or hospital based setting. For this review, prehabilitation was defined as either a uni-modal or multi-modal intervention or programme including either exercise, nutrition and/or psychological wellbeing. All study designs were included in this scoping review providing that they met the inclusion criteria as outlined in Table 1. Protocols for ongoing or upcoming lung cancer prehabilitation studies were included in the review, as the authors felt these provided key insights into the delivery and proposed outcomes for prehabilitation within this field. All articles available in English were included.

Table 1.

Eligibility criteria

Inclusion criteria Exclusion criteria
Population Adults aged ≥ 18 years old with a diagnosis of lung cancer Studies addressing other tumour sites
Intervention Unimodal or multimodal* prehabilitation interventions prior to lung cancer treatment Not applicable
Comparator Usual care or another type of intervention Not applicable
Outcome

The intended and unintended outcomes for lung cancer patients participating in a prehabilitation programme

The effectiveness of prehabilitation programmes

Not applicable
Study design

Quantitative studies

Qualitative studies

Mixed method studies

If relevant systematic reviews identified, primary papers will be included

Study protocols for ongoing or upcoming prehabilitation studies specific to lung cancer

Published from 2016 up to and including 03 February 2023

Commentaries

Opinion articles

Book reviews

Conference abstracts

Social media posts

Blogs

Podcasts

Language Written in the English language Articles published in a language other than English due to limited translation resources

*Multi-modal: delivery of two or more non-pharmacological interventions (for example exercise, nutrition and/or psychological wellbeing)

3. Search strategy.

The literature search was undertaken by a research librarian using pre-defined search terms between the period of 2016 and 03 February 2023. This time period was chosen due to a rapid emergence of the use of prehabilitation within cancer care to improve health outcomes and reduce healthcare costs since the publication of a key research paper by Silver in 2015 [30]. This was followed by the Macmillan prehabilitation evidence and insight review [31] and subsequent publication of the Macmillan prehabilitation guidance [32]. A total of five databases were searched incorporating medical, nursing, allied health and psychological literature relevant to prehabilitation and lung cancer: Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, Emcare, Medical Literature Analysis and Retrieval System Online (MEDLINE) and Psychological Information Database (PsycINFO). The major search terms ‘lung’, ‘cancer’ and ‘prehabilitation’ were used.

4. Evidence screening and selection.

All duplications were removed using the Zotero deduplication function. All retrieved abstracts for possible inclusion were independently screened by the first and last author. There was a consensus between both authors and thus, a third reviewer was not required.

5&6. Data extraction and analysis.

All articles reviewed for inclusion were obtained in full text. The JBI reviewers manual for evidence synthesis was used to create a synthesis matrix for data extraction [33]. Data extraction included: study title, year of publication, country, study design, sample size, type of participants, study aim, type of prehabilitation intervention used, key findings, strengths and limitations.

Results

A total of 31 articles were included in this scoping review; see Fig. 1. In some studies, pulmonary rehabilitation was described as prehabilitation. After discussion with authors conducting the review, it was agreed that pulmonary rehabilitation is a separate intervention, acknowledging that it may complement prehabilitation in the long-term. Therefore, studies that focused on pulmonary rehabilitation were excluded from this review.

Fig. 1.

Fig. 1

PRISMA flow diagram of the scoping review process

The results of this review are presented in a narrative form in Tables 2 and 3.

Table 2.

Summary of all studies meeting the eligibility criteria and subsequently used in this present scoping review

Title and year Country of origin Aims and purpose Study population / sample size Study design/type Key findings related to the scoping review objectives Strengths/limitations
Prehabilitation sessions can be provided more frequently in a shortened regimen with similar or better efficacy in people with non-small cell lung cancer: A randomised trial 2022 [34] France To evaluate the relative effect of condensing 15 prehabilitation sessions into a 3-week regimen compared with a 5-week regimen N = 36 (18 in the intervention arm and 18 in the control arm) patients with Non-Small Cell Lung Cancer (NSCLC) and moderate - high risk of postoperative complications Randomised controlled trial Condensing prehabilitation sessions led to similar or better improvement in cardiorespiratory fitness and did not decrease adherence or increase adverse events

Strengths: Concealed allocation, blinded assessment of the primary outcome and intention-to-treat analysis

Limitations: External validity is limited with regards to inpatient or homebased programmes

Multimodal prehabilitation for lung cancer surgery: A randomised controlled trial 2021 [35] Canada

To investigate

the effect of a personalised and structured multimodal

intervention on postoperative functional recovery

N = 95 (52 in the prehab arm and 43 in the rehab arm) lung cancer patients scheduled for NSCLC surgical resection Randomised controlled trial

No difference in functional capacity during the perioperative period between the 2 groups

Eight weeks after surgery, both groups returned to baseline functional capacity

Limitations: A four-week prehabilitation intervention may not be highly translatable to patients with short durations between diagnosis and surgery. Patients who did not speak English or French were excluded
Feasibility of a novel mixed-nutrient supplement in a multimodal prehabilitation intervention for lung cancer patients awaiting surgery: A randomised controlled pilot trial 2021 [36] Canada To investigate the feasibility of delivering a novel four-week multimodal prehabilitation intervention and its effects on preoperative functional capacity and Health-Related Quality Of Life (HRQOL) compared to standard hospital care N = 34 (24 in the intervention arm and 10 in the control arm) patients with stage I, II or IIa lung cancer awaiting elective thoracotomy Randomised controlled trial

A multimodal prehabilitation intervention for lung cancer patients awaiting surgery is feasible as demonstrated by 84.1% adherence to the prescribed intensity of the supervised exercise program, 88.2% adherence to the self-reported home-based exercise program and 93.2% adherence to the nutritional supplement

No statistical differences in the six minute walk test or HRQOL between groups

Strengths: One of the first studies to include a specifically tailored preoperative nutritional intervention beyond dietary advice and/or whey protein supplementation in lung cancer patients undergoing surgery. Flexibility of the exercise intervention

Limitations: Nature of the study design (an open-label trial) could have led to a possible placebo effect in the prehabilitation group and self-supplementation in the control group. Due to the behavioural nature of the intervention, control patients may have sought out similar exercises on their own, as evidenced by the significant increase in self-reported moderate -vigorous intensity physical activity. High proportion of missing data at the preoperative visit, due to the COVID-19 pandemic. No data on adherence to the anxiety-reducing component of the intervention

Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PREHIIT): Protocol for a randomised controlled Trial 2020 [37] Ireland To examine the influence of exercise prehabilitation on physiological outcomes and postoperative recovery and through evaluation of health economics, the impact of the programme on hospital costs N = 78 (39 in the intervention arm and 39 in the control arm) patients scheduled for either an oesophagectomy or major lung resection Randomised controlled trial (Protocol) Planned outcomes: Primary outcomes: Cardiorespiratory fitness. Secondary outcomes: Post-operative morbidity, pulmonary and physical performance and quality of life

Strengths: A randomised controlled trial. An examination of the economic implications of the exercise prehabilitation programme will be done as part of the outcomes

Limitations: Absence of nutritional screening despite nutritional adequacy being examined. Inclusion of both lung and oesophageal cancer patients

Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: A randomised clinical trial 2020 [38] Denmark To evaluate the effect of a physical exercise program comprising 12 weeks of supervised, structured aerobic, strength, and relaxation training twice weekly for patients with advanced inoperable lung cancer N = 218 (110 in the intervention arm and 108 in the control arm) patients with stage IIIb-IV NSCLC Randomised controlled trial No significant difference between the intervention and control group in VO2 peak. Statistically significant difference in strength; leg press (p = 0.01), leg extension (p =  < 0.01), chest press (p =  < 0.01) and lateral pull down (p = 0.04) and in social well-being (p = 0.04), anxiety (p = 0.02) and depression (p = 0.01) between the intervention and control group Limitations: 36.6% drop out rate. Adherence to the intervention was only 44%. Patients unable to attend the hospital for the exercise program were excluded
Cost-effectiveness of a technology supported multimodal prehabilitation program in moderate-to-high risk patients undergoing lung cancer resection: Randomised controlled trial protocol 2020 [39] Spain

To evaluate the cost-effectiveness of a multimodal prehabilitation program supported by information and

communication technologies

N = 158 (79 in the intervention arm and 79 in the control arm) Randomised controlled trial (Protocol) Planned outcomes: (i) Patient and professional experience, (ii) Population health-based outcomes (e.g. hospital length of stay, number and severity of postoperative complications, peak oxygen uptake and levels of systemic inflammation) and (iii) Healthcare costs

Strengths: One of the first studies to look at cost-effectiveness and factors which could modulate service adoption

Limitations: Patients without access to a smartphone will be excluded

Preoperative respiratory muscle endurance training improves ventilatory capacity and prevents pulmonary postoperative complications after lung surgery 2020 [40] France To evaluate preoperative Respiratory Muscle Endurance Training (RMET) on respiratory muscle capacity and postoperative complications N = 26 patients (14 in the intervention arm and 12 in the control arm) undergoing lung resection for NSCLC Randomised controlled trial

Statistically significant improvement in respiratory muscle endurance (p = 0.001)

and reduction in pulmonary postoperative complications (p = 0.037) in the intervention group compared to the control group

Strengths: One of the first studies to demonstrate the benefits of prehabilitation via RMET

Limitations: Small sample size. Possible selection bias – highly motivated group of participants

Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: A randomised trial 2019 [41] China To investigate the influence of preoperative physical training combining aerobic and breathing exercises on surgical lung cancer patients with impaired lung function N = 68 (34 in the intervention arm and 34 in the control arm) NSCLC patients Randomised controlled trial Preoperative physical training (aerobic and breathing exercises) can improve exercise capacity, as evidenced by a statistically significant increase in distance covered by the 6 min walk test (6MWD) (p = 0.004), reduction in post-operative pulmonary complications (p = 0.022), shorter length of stay (p =  < 0.001) and lower in-hospital costs (p = 0.016). No statistically significant differences in lung function or quality of life, except for the emotional function of the EORTC QLQ-C30 (p = 0.001) between groups

Strengths: Inclusion of a cost-effectiveness analysis of the intervention

Limitations: Generalisability of findings is limited as it’s a small single centre study with the inclusion of non NSCLC patients

Pre-operative high intensity interval training is effective and safe in deconditioned patients with lung cancer: A randomised clinical trial 2019 [42] Switzerland To examine the effect of prehabilitation in patients diagnosed with lung cancer N = 151 (74 in the intervention arm and 77 in the control arm) patients with NSCLC stage IIIa or less Randomised controlled trial Short-term high intensity interval training is feasible in deconditioned patients as evidenced by 87% adherence. It increases cardio-respiratory fitness and walking capacity as evidenced by a statistically significant increase in high-intensity interval training power (p =  < 0.001), heart rate (p =  < 0.01), aerobic capacity (p = 0.004) and 6MWD (p =  < 0.001) in the intervention group compared to usual care

Strengths: Demonstrated benefit of exercise prehabilitation in a short time period (8 training sessions over 3 weeks). High adherence.

Limitations: Absence of nutrition and psychological components of prehabilitation

Two week multimodal prehabilitation program improves perioperative functional capability in patients undergoing thoracoscopic lobectomy for lung cancer: A randomised controlled trial 2019 [43] China To investigate the effects of a two week, homebased, multimodal prehabilitation program on perioperative functional capacity and other outcomes N = 73 (37 in the intervention arm and 36 in the control arm) patients with stage I-III NSCLC undergoing Video Assisted Thoracoscopic Surgery (VATS) lobectomy Randomised controlled trial

Statistically significant improvement in the 6 min walk test (6MWT) (p =  < .001) and forced vital capacity (p = .0.21) in the intervention group compared to the control group (p =  < .001)

No difference in lung function, disability, psychological assessment, length of stay, postoperative complications and mortality

Strengths: Tri modal prehabilitation programme (nutrition, exercise and psychology)

Limitations: Patients only included if they were having a VATS lobectomy, all other lung cancer surgeries were excluded. No information on lifestyle changes

Precision-Exercise-Prescription (PEP) in patients with lung cancer undergoing surgery: Rationale and design of the PEP study trial 2018 [44] United States of America To test the clinical effectiveness and feasibility of a personalised exercise intervention in patients with lung cancer undergoing surgery N = 200 (100 in the intervention arm and 100 in the control arm) patients with primary lung cancer stage I, II or IIIa or secondary lung cancer undergoing surgery Randomised controlled trial (protocol) Planned outcomes: Primary outcome: Level of physical function assessed by the 6MWT at 2 months post-surgery. Secondary outcomes: Quality Of Life (QOL), fatigue, self-efficacy, length of stay, complications, readmission, pulmonary function and treatment-related costs up to 6 months post-surgery

Strengths: One of the first RCT’s to examine a personalised exercise programme for patients with primary and secondary lung cancer across the continuum of care from pre surgery to post surgery.

Limitations: Patients unable to follow directions and complete questionnaires and exercise diaries in English would be excluded

A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer 2017 [45] Canada To compare the impact of medical Qigong and standard exercise therapy on anxiety and depression levels and QOL and to establish whether medical Qigong or standard exercise training is superior for improving functional capacity and reducing symptoms N = 24 patients with stage three or four NSCLC or gastrointestinal cancer Randomised controlled trial No significant differences in anxiety, depression or QOL between Qigong and standard exercise therapy. However, standard exercise therapy was superior to Qigong as demonstrated by statistically significant improvements in perceived strength (p = 0.05) and walking distance (p = 0.02)

Strengths: One of the first studies to compare Qigong with another exercise intervention

Limitations: Study was underpowered. Only 19 patients completed both assessments

Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomised controlled trial 2017 [46] Australia To assess whether a 2-month physical activity intervention improves fatigue and QOL N = 112 (56 in the intervention arm and 55 in the control arm) patients with stage III/IV NSCLC or Small Cell Lung Cancer (SCLC) Randomised controlled trial No significant differences in fatigue, QOL, symptoms, physical or functional status or survival between the groups

Strengths: Physical activity intervention adherence was good (69%), demonstrating that advanced lung cancer are able to participate in structured physical activity programmes

Limitations: Selection bias – motivated group

Preoperative exercise training prevents functional decline after lung resection surgery: A randomised, single-blind controlled trial 2017 [47] Spain To investigate the effects of a preoperative exercise programme in patients with lung cancer undergoing VATS N = 22 (10 in the intervention arm and 12 in the control arm) patients with suspected or confirmed diagnosis of NSCLC Randomised controlled trial Statistically significant improvement in exercise tolerance (p = 0.0001), the physical summary component of the Short Form (SF) 36 survey (p = 0.008) and muscle strength (p =  < 0.01) in the intervention arm compared to the control group. There were no significant differences between groups after surgery. However, 3 months post-surgery, there were statistically significant differences in mean change of exercise capacity (p = 0.005), physical summary component (p = 0.001) of the SF-36 and upper (p = 0.045) and lower body strength (p = 0.002)

Strengths: Demonstrated that a preoperative exercise based programme can improve exercise capacity, muscle strength and the physical component of health related quality of life in patients with lung cancer

Limitations: Small study with a high dropout rate – of the 20 patients randomised to the prehabilitation group, only 50% completed the study

Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: A randomised controlled study 2017 [48] Switzerland To evaluate the impact of adding rehabilitation with High Intensity Interval Training (HIIT) before lung cancer surgery to enhance cardio-respiratory fitness and improve long-term postoperative outcome N = 151 (74 in the intervention arm and 77 in the control arm) patients with suspected or confirmed stage IIIa or less NSCLC Randomised controlled trial A HIIT program before lung cancer resection did not improve clinical and functional outcomes at 1 year after surgery as evidenced by no statistical significant difference in survival, pulmonary function or cardiorespiratory difference between the 2 groups

Strengths: One of the first studies to examine the impact of prehabilitation on long-term outcomes after resection

Limitations: A third of patients did not complete the pulmonary function and cardiopulmonary exercise tests for unknown reasons

Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery: A randomised controlled trial 2017 [49] Switzerland To evaluate and compare short-term preoperative HIIT to usual care by assessing cardio-respiratory fitness parameters and the incidence of postoperative complications N = 151 (74 in the intervention arm and 77 in the control arm) patients undergoing NSCLC resection Randomised controlled trial

Preoperative HIIT resulted in statistically significant improvements in peak oxygen consumption (p = 0.003) and 6MWD (p < 0.001)

There were no statistically significant differences in complication rates between groups

Strengths: Demonstrated the safety and effectiveness of a short-term exercise training program in improving aerobic performance

Limitations: Study was underpowered. 25% did not experience any benefit in aerobic fitness despite attending the prescribed training sessions

Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomised study 2016 [50] Turkey To investigate the benefit of preoperative nutritional support for NSCLC patients who underwent anatomic resection N = 58 (31 in the intervention arm and 27 in the control arm) patients with NSCLC Randomised controlled trial

Preoperative nutrition provided a statistically significant reduction in complications (p = 0.049) and chest tube removal time (p = 0.019) in patients who were in the intervention arm compared to the control group

There was also a statistically significant reduction of 25% in postoperative albumin levels in patients in the control arm compared to only a 14% reduction in those in the intervention arm (p < 0.001)

Strengths: One of the first studies examining the effect of nutritional prehabilitation in patients with NSCLC

Limitations: Disproportionate number of males versus females; 54 versus 4 respectively. Excluded malnourished patients and patients with a low Body Mass Index (BMI). Changes in albumin could be multifactorial

Effect of prehabilitation on ventilatory efficiency in non–small cell lung cancer patients: A cohort study 2019 [51] France To assess the effect of prehabilitation on the minute ventilation / carbon dioxide production slope (VE/VC02) and its relationship with VO2peak N = 50 patients with NSCLC Cohort study No statistically significant change in VE/VCO2 slope (p = 0.09), length of hospital stay (p = 0.55) and post-operative complications (p = 0.50) from baseline to post prehabilitation. However, there was a statistically significant increase in VO2peak (p = 0.01) and cardiorespiratory parameters (p = 0.01) from baseline to post prehabilitation

Strengths: One of the first studies to evaluate the effect of prehabilitation before lung resection for NSCLC on VE/VCO2 slope

Limitations: Retrospective study design. Exercise intensity was not accounted for

Impact of prehabilitation on morbidity and mortality after pulmonary lobectomy by minimally invasive surgery: A cohort study 2018 [52] France To determine whether participation in a prehabilitation program would improve outcomes after surgery and lower morbidity according to the Clavien-Dindo classification N = 38 (19 in the intervention arm and 19 in the control arm) patients with NSLC stage IIIA or less who had pulmonary lobectomy by minimally invasive surgery Cohort study

Statistically significant difference in favour of the prehabilitation group with a Clavien-Dindo grade of ≤ 2 (p = 0.02) and fewer postoperative complications (p = 0.03)

No significant difference between the two groups in length of stay and severity of complications

Strengths: One of the first studies to focus on prehabilitation and the severity of post-operative complications using the Clavien-Dindo classification

Limitations: Small sample size. Post-operative complications were only recorded up to 30 days post-surgery. Patients unable to attend the hospital for the exercise program were excluded

Application and practice of trimodal prehabilitation model in preoperative management of patients with lung cancer undergoing video-assisted thoracoscopic surgery 2023 [53] China To analyse the application of trimodal prehabilitation model in preoperative management of patients with lung cancer undergoing VATS N = 148 (74 in the intervention arm and 74 in the control arm) stage I-II NSCLC patients due to undergo VATS Prospective study Statistically significant improvement in the 6MWT and activity levels (p values not provided) and a reduction in the Hospital Anxiety Depression Scale (HADS) and post-operative complications (p values not provided) between groups post intervention

Strengths: Tri modal prehabilitation programme (nutrition, exercise and psychology)

Limitations: Results to be interpreted with caution owing to the absence of P values

Pre-treatment optimisation with pulmonary rehabilitation in lung cancer: Making the inoperable patients operable 2021 [54] United Kingdom To determine whether pre-operative prehabilitation, by improving clinical parameters, (i) makes patients suitable for surgery who were considered inoperable and (ii) thereby allows them to safely receive curative surgery with reduced morbidity and mortality N = 216 lung cancer patients Prospective study

Clinically and statistically significant improvement in dyspnoea scores (p = 0.00002) performance status (p = 0.003) level of activity (p =  < 0.00001) and frailty (p = 0.00058) from baseline to post prehabilitation intervention

42.8% underwent surgery following prehabilitation

Strengths: Prehabilitation intervention is as short as 2 weeks, which is more translatable to patients with short durations between diagnosis and surgery. Prospective study so all data is collected in real time

Limitations: Lack of a control group. No information on nutrition

Neoadjuvant prehabilitation therapy for locally advanced non–small-cell lung cancer: Optimizing outcomes throughout the trajectory of care 2022 [55] Canada To assess whether neoadjuvant prehabilitation helps to optimise outcomes N = 141 (20 in the intervention arm and 121 in the control arm) lung cancer patients who underwent neoadjuvant treatment followed by surgery Retrospective study Statistically significant improvement in the 6WMT (p = .1), self-reported functional status (p = .03) and HADS (p = .005) in the intervention group compared to the control group

Strengths: Tri modal prehabilitation programme (nutrition, exercise and psychology). Use of validated tools for assessment of nutrition, exercise and psychological wellbeing

Limitations: Significant difference in the number of patients between both arms

Malnourished lung cancer patients have poor baseline functional capacity but show greatest improvements with multimodal prehabilitation 2021 [56] Canada To characterise the presence of malnutrition, examine the association between malnutrition and baseline functional capacity and the extent to which patients benefit from preoperative multimodal prehabilitation N = 162 (number in the prehabilitation group vs control not specified) lung cancer patients undergoing lung cancer resection Retrospective study High nutrition risk patients had significantly lower baseline functional capacity compared with those who were low risk (p = 0.022), but experienced significant improvements in preoperative functional capacity upon receiving multimodal prehabilitation (p = 0.01)

Strengths: One of the first prehabilitation studies to look at the association between patients categorised as being high nutritional risk and functional capacity

Limitations: High proportion of missing data (30%). Change in nutritional status was not measured, as the assessment tool was not repeated at follow up visits. Study was not powered

Feasibility and outcomes of a real-world regional lung cancer prehabilitation programme in the UK 2022 [57] United Kingdom To evaluate the feasibility, uptake and outcomes of the Prehab 4 Cancer service delivery model during the 11 months before COVID-19 restrictions N = 377 lung cancer patients with a treatment recommendation of surgical resection Feasibility study The programme was feasible at scale with high uptake and had a positive impact on preoperative physiological and subjective functional assessments, providing a framework for wider implementation

Strengths: Multi- disciplinary team approach. Triage based on the principles of NHS England’s personalised care model

Limitations: Risk of selection bias owing to no control group. Incomplete end of prehabilitation assessment data. Only 120 patients completed the programme; 1 in 5 opted not to participate in the programme and the reasons for this are poorly understood

Feasibility of setting up a pre-operative optimisation ‘prehab’ service for lung cancer surgery in the UK 2020 [58] United Kingdom To assess the feasibility of setting up a prehabilitation service for lung cancer surgery N = 50 lung cancer patients due to undergo surgery Feasibility study A lung cancer prehabilitation programme is feasible and safe as demonstrated by a statistically significant improvement in forced expiratory volume (p = 0.0045), 6MWT (p =  < 0.0001), sit to stand (p = 0.0011) and QOL (p = 0.0213) scores from baseline to post prehabilitation intervention and no adverse events Strengths: Use of the Orsmond and Cohn framework for feasibility studies to assess feasibility
A feasibility study of an unsupervised, pre-operative exercise program for adults with lung cancer 2020 [59] United States of America To explore the feasibility, acceptability and perceived utility of the provision of a wearable fitness device and an exercise prescription from a surgeon N = 30 patients with stage I, II or III lung cancer scheduled for surgery Feasibility study A wearable fitness device and exercise prescription is feasible and acceptable as evidenced by 79% completing the pre-operative study activities. 71% successfully synchronised their device during the pre-operative period. Data was transmitted from the device to the study team for an average of 70% of pre-operative days

Strengths: High engagement with the device and study assessments

Limitations: Some patients voiced confusion as to how to use the device, which could limit future trials with older populations. Questions surrounding the generalisability of findings as patients who were willing to enrol on the programme may be more active than an average lung cancer patient. Patients who did not speak English were excluded

Pre-radiotherapy daily exercise training in non-small cell lung cancer: A feasibility study 2019 [60] Denmark To examine the feasibility of an individual, supervised, structured moderate-to-high intensity cycle ergometer exercise training immediately before radiotherapy N = 15 patients with locally advance NSCLC Feasibility study Feasible and safe as demonstrated by 90% attendance to exercise, 88% adherence to full exercise participation and no adverse events

Strengths: First study to test whether daily individualised structured exercise is feasible and safe in patients with advance NSCLC. Ease of access for patient participation

Limitations: Small sample size. Selection bias – motivated group

Patients’ and healthcare professionals’ views on a pre-and post-operative rehabilitation programme (SOLACE) for lung cancer: A qualitative study 2021 [61] United Kingdom To explore patients and healthcare professionals views and experiences of a pre-and post-operative rehabilitation intervention N = 25 (17 patients who had early-stage lung cancer and had surgery + 8 healthcare professionals who work with lung cancer patients in pre and post-surgical care) Qualitative study

The SOLACE service was positively perceived by patients and healthcare professionals. Patients valued the provision of tailored support/advice and peer support and reported benefits to their health and well-being

Barriers to patient uptake of the classes included time constraints, motivation and access for patients who lived at a distance

Virtual support may address equality of access to service for those who live at a distance from the hospital

Strengths: Provided an understanding of the value of a pre and post rehabilitation programme. The semi-structured interviews shed light on what was acceptable as well as the barriers to participation

Limitations: Views of patients who did not participate in the exercise classes were not represented in the interviews. Individuals who did participate in the exercise programme were more likely to be highly motivated to participate. Not an ethnically diverse group, therefore generalisability of the findings is limited. Equality of access to the service for those who live a distance away from the hospital

Attitudes and perceptions to prehabilitation in lung cancer 2020 [62] Australia To determine the acceptability and perceived benefit of prehabilitation in lung cancer among thoracic surgeons N = 28 thoracic surgeons Online cross-sectional survey

91% were willing to delay surgery to optimise patients via prehabilitation

The main barriers to prehabilitation were patient comorbidities and access to allied health professionals

92% believe that further research into prehabilitation in lung cancer is warranted

Strengths: One of the first studies to look at the attitudes and perceptions of prehabilitation amongst thoracic surgeons

Limitations: Response rate was only 14%

Potential effectiveness of a surgeon-delivered exercise prescription and an activity tracker on pre-operative exercise adherence and aerobic capacity of lung cancer patients 2021 [63] United States of America To determine the level of Moderate-Vigorous Physical Activity (MVPA) and change in aerobic capacity after participation in a home-based pre-operative exercise intervention N = 18 patients with stage I-III lung cancer due to undergo surgery Proof of concept study

Mean MVPA per day: 20.4 min during the pre-operative period. On average, patients met the goal of 30 min of MVPA on 16.4% of the days during the pre-operative period

No statistical significant difference found in the 6MWT between baseline and post MVPA (p = 0.14). 47% demonstrated a clinically significant improvement of 14 m or more, highlighting that a surgeon-delivered exercise prescription plus an activity tracker may promote clinically significant improvement in aerobic capacity and MVPA engagement

Strengths: One of the first studies to look at the level of adherence when exercise is enthusiastically prescribed by a surgeon and objectively measured

Limitations: Patients who did not have access to the internet were excluded. An objective measure of pre-intervention MVPA to compare MVPA levels during the intervention was not obtained. The Garmin Vivoactive heart rate device used had not been validated for MVPA assessment among the general population or among pre-operative cancer patient populations

Prehabilitation in thoracic cancer surgery: From research to standard of care 2021 [64] Canada To determine whether personalised, stepped prehabilitation care is a feasible, safe, and effective implementation strategy N = 81 (45 in the intervention arm and 36 in the control arm) lung cancer patients due to undergo lung cancer surgery Quality Improvement Project A personalised, stepped prehabilitation program targeting high-risk patients undergoing elective lung cancer surgery is feasible, safe, and effective as evidenced by a statistically significant improvement in 6MWD (p = 0.001), oxygen uptake (p = 0.004) and hospital length of stay (p = 0.101) after prehabilitation. There were no significant differences in the number of complications and there were no adverse events

Strengths: Tri-modal (nutrition, exercise and psychological wellbeing) prehabilitation approach

Limitations: Selection bias - only patients who lived in the metropolitan area and had an expected waiting time of about four-to-five weeks before surgery were referred. Limited external validity as no predefined and universal outcome variables used or consistent time points. The intervention and control groups were not balanced

Table 3.

Description of the prehabilitation interventions using a modified version of the TIDieR checklist

Study What Who provided How Where When and how much Tailoring How well (actual/planned)
Components Description
Prehabilitation sessions can be provided more frequently in a shortened regimen with similar or better efficacy in people with non-small cell lung cancer: A randomised trial (Randomised controlled trial) [34]

• Exercise

• Wellbeing

Not based on a model or theory, but on the findings of a previous study which found that patients who completed ≥ 15 sessions showed more improvement in cardiorespiratory measures after the prehabilitation program than those who performed fewer sessions

Exercise: Consists of aerobic endurance training on a cycle ergometer, peripheral muscle strengthening and inspiratory muscle strengthening

Wellbeing: Smoking cessation support and education on mucus clearance techniques, deep-breathing, directed and protected coughing, and postoperative mobilisation

Physiotherapist

Exercise: One to one and group sessions

Wellbeing: Support and education was delivered during the first individual session and reminders and advice were provided during the following group sessions

Information not provided

Intervention arm: 5 × 90-min sessions per week for 3 weeks

Control arm: 3 × 90-min sessions per week for 5 weeks

Load / intensity / resistance increased according to individual tolerance Mean estimates of VO2peak and VE/VCO2 slope favoured the dense prehabilitation regimen and the confidence intervals indicated that the effects are as good as or better than the control regimen. However, this was not associated with a reduction in postoperative complications in this study
Multimodal prehabilitation for lung cancer surgery: A randomised controlled trial (Randomised controlled trial) [35]

• Exercise

• Nutrition

• Wellbeing

Not based on a model or theory, but research that although exercise training has been shown to significantly improve physical function, lung cancer patients are at nutritional risk due to a reduced food intake and often experience psychological stress which could lead to a delayed recovery and mortality

Exercise: Moderate-vigorous intensity aerobic training and resistance training

Nutrition: Patients screened using validated tools, advised to aim for 1.5 g/kg/d of protein and prescribed whey protein supplements if required

Wellbeing: Relaxation exercises based on imagery, visualisation and deep breathing to help reduce anxiety

Exercise: Certified kinesiologist

Nutrition: Registered dietitian

Wellbeing: Psychology trained personnel

Exercise: Personalised exercise prescription

Nutrition: All patients screened using the Patient Generated Subjective Global Assessment (PG-SGA) and the Nutritional Risk Screening tool. Daily protein calculated at 1.5 g/kg ideal body weight

Wellbeing: A compact disc with relaxation exercises provided

Home-based unsupervised programme

Immediately after baseline assessment (approximately 4 weeks prior to surgery) and up to 8 weeks after surgery

Exercise: 30 min of moderate-vigorous intensity aerobic training 3 days a week + resistance training (8–12 repetitions) and stretching exercises 3 days a week

Nutrition: 1.5 g/kg ideal body weight of protein per day + protein supplements within 1 hour of exercise

Wellbeing: 2–3 times a week

Exercise: Tailored to a patient’s preferred type of exercise and fitness level

Nutrition: Advice given based on a 3 day food diary completed at the time of enrolment

Wellbeing: Information not provided

No difference in the trajectory of functional capacity post-surgery

No difference in median hospital length of stay, but 42% versus 16% were discharged post-operatively by day two. No discussion on the influence of nutritional optimisation and anxiety reducing strategies

Feasibility of a novel mixed-nutrient supplement in a multimodal prehabilitation intervention for lung cancer patients awaiting surgery: A randomised controlled pilot trial (Randomised controlled trial)

[36]

• Exercise

• Nutrition

• Wellbeing

Not based on a model or theory, but the hypothesis that during the preoperative period the novel multimodal prehabilitation intervention would be feasible and improve preoperative functional capacity compared to standard hospital care

Exercise: Consisted of supervised and unsupervised moderate aerobic exercise and resistance exercise

Nutrition: Individualised dietary assessment to meet protein intake of > 1.2 g/kg/d and energy of 25–30 kcal/kg/d + a whey protein isolate supplement with leucine + a daily fish oil supplement with vitamin D

Wellbeing: Relaxation exercises based on imagery, visualisation and deep breathing

Exercise: Kinesiologist

Nutrition: Dietitian

Wellbeing: Psychology trained personnel

Exercise: Personalised exercise prescription

Nutrition: One to one dietary assessment based on intake, anthropometry, nutrition-impact symptoms, biochemistry and a nutrition-focused physical exam

Wellbeing: One to one sessions and patients were given a compact disc with relaxation exercises to be performed at home. Adherence was assessed based on responses in a patient information booklet

Hospital based combined with unsupervised sessions at home

4 weeks prior to surgery:

Supervised exercise: 1 h / week of aerobic exercise + resistance exercises: 1–2 sets of 8–15 repetitions for 30 min

Unsupervised exercise: 30 min of moderate aerobic exercise + resistance exercises every second day

Nutrition: Whey protein supplementation twice a day

Wellbeing: 2–3 times a week

The exercise program was individualised based upon initial assessments. Dietary advice was individualised

High adherence rates to suggest feasibility for the exercise and nutritional component, but no data on the psychological component

Recruitment rate was 58.6%

No improvement observed in preoperative functional capacity

Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PREHIIT):

Protocol for a randomised controlled trial (Randomised controlled trial protocol)

[37]

• Exercise

• Nutrition

Not based on a model or theory, but based on preliminary evidence that 12–15 sessions of HIIT significantly improves cardio-pulmonary fitness in low-fit older adults undergoing

lobectomy and hepatic resection, however further evaluation in larger cohorts and in those with highest postoperative risk is required

Exercise: Supervised

HIIT programme

Nutrition: Tailored dietetic assessment to ensure nutritional adequacy is maintained throughout the intervention

Exercise: Physiotherapist

Nutrition: Dietitian

Exercise: One to one supervised sessions on a cycle ergometer at a time convenient to the patient

Nutrition: Ensuring an adequate dietary energy (25-30 kcals/kg/day) and protein intake

(1.25–1.5 g/kg/day)

Hospital based

Exercise: At least 2 weeks up to 5 days a week with each session lasting 40 min

Nutrition: Information not provided

Exercise and dietary intervention will be tailored to the individual The following will be measured at diagnosis, baseline and post intervention prior to surgery: cardio-pulmonary fitness (CPET), pulmonary and physical performance (maximal inspiratory pressure, peripheral muscle strength, short physical performance battery, International Physical Activity Questionnaire) and QOL (EORTC). The following will be measured at post-operative recovery: post-operative morbidity index, post-operative morbidity (Clavien-Dindo classification), complex complications index, mortality, length of stay, self-reported functional recovery at 30 days and QOL (EORTC, EQ5DL). A sub cohort of patients will take part in a semi-structured interview to feedback on how the study has impacted their preparation for surgery. Economic evaluation will also be undertaken. Discharge destination, use of community health services and EQ5D5L scores will be collected to assess if the intervention has longer term effects beyond discharge

Effects of an exercise intervention for patients with advanced inoperable

lung cancer undergoing chemotherapy: A randomised clinical trial

(Randomised controlled trial)

[38]

• Exercise

No model or theory base reported

Physical training and relaxation comprising of strength training, aerobic training and stretching A clinical nurse specialist or physiotherapist screened all patients prior to participation. A research physiotherapist delivered the exercise training Supervised group training consisting of stationary cycling and strength training Information not provided 2 × a week for 1.5 h over 12 weeks The exercise sessions were tailored to the patient’s fitness level Attrition rate was 37% due to death (n = 12), refusal to participate (n = 22), disease progression (n = 20), and absence from test (n = 27). All patients were undergoing concurrent systemic treatment and 67% received radiotherapy. No significant difference seen in the primary outcome; peak V02

Cost-effectiveness of a technology supported

multimodal prehabilitation

program in moderate-to-high risk patients

undergoing lung cancer resection: Randomised controlled trial protocol

(Randomised controlled trial)

[39]

• Exercise

• Nutrition

• Wellbeing

Not based on a model or theory, but the hypothesis that surgical lung cancer patients

are likely to benefit from prehabilitation as they usually have a significant

reduction in functional capacity from multifactorial origin

Intervention arm: Exercise: High-intensity endurance exercise, strength training and a personalised pedometer based program. Nutrition: Individualised dietary counselling to meet 1.5–2 g/kg/d of protein + a whey protein powder or casein supplement

Wellbeing: Smoking cessation and cognitive behavioural therapy

Control arm: patients will receive advice on physical activity, smoking cessation and alcohol intake. If deemed at risk of malnutrition, patients will receive nutritional intervention

Exercise: Physiotherapist

Nutrition: Dietitian

Wellbeing: Clinical health psychologist

Exercise: One to one on a cycle ergometer and use of a physical activity tracker linked to a mobile app

Nutrition: Personalised dietary counselling with educational material and follow-up surveys in the mobile app

Wellbeing: Group sessions and audio guides for coping strategies and exercises in the mobile app

Community based and via a mobile app

Prior to surgery. Duration not specified

Exercise: 3 × week

Nutrition: Information not provided

Wellbeing: 1 × week

Exercise: Endurance training will be tailored to the individual according to symptoms (using the modified Borg scale) and the strength training will be adapted to an individual’s tolerance

Nutrition: Individualised dietary assessment

Wellbeing: Information not provided

Study outcomes to follow a quadruple aim approach. (1) Patient experience (Person Centred Coordinated

Experience Questionnaire, Nijmegen Continuity Questionnaire and focus groups and structured interviews to identify facilitators and barriers to prehabilitation) (2)

Population health-related outcomes (Length of stay, postoperative complications, readmissions, physical activity, wellbeing and nutrition markers) (3) Healthcare costs (4)

Healthcare

professionals’ perspective (Advancing Care coordination and Telehealth deployment at Scale questionnaire, focus groups and structured interviews)

Preoperative respiratory muscle endurance training improves ventilatory capacity and prevents pulmonary postoperative complications after lung surgery

(Randomised controlled trial)

[40]

• Exercise

Not based on a model or theory, but based previous RCTs which have showed significant improvements in respiratory muscle endurance and exercise capacity in patients with Chronic Obstructive Pulmonary Disease (COPD) patients following RMET

RMET, consisting of isocapnic hyperpnoea and usual pre-operative chest therapy A physical therapist Using a Spirotiger® device. The RMET was supervised once a week by the same physical therapist Hospital and home based Pre-operatively. Patients receive 12 sessions of RMET over three weeks and are asked to complete a 30-min training session daily. RMET is performed on 2 consecutive days and rested for 1 day RMET was tailored to each patient via use of the Spirotiger® device

86% adherence to the training programme.

Minute ventilation and endurance time increased significantly after RMET.

The number of post-operative complications was significantly lower in those who received RMET

Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: A randomised trial (Randomised controlled trial) [41]

• Exercise

No model or theory base reported

Consisted of physical training including breathing exercises and aerobic exercise Nurse specialists and physical therapists

Breathing exercises: Using a volumetric incentive spirometer

Aerobic exercise: Using a Nu-Step instrument

Information not provided The intervention was provided over 1 week. Breathing exercises: 3 × day and aerobic exercise: 30 min a day Information not provided Significant difference in the distance covered in the 6MWT in the intervention arm compared to the control group, indicating that short-term high-intensity training regimen could improve cardiopulmonary endurance. No significant difference in lung function or quality of life (except for emotional function) between the two groups, suggesting that intense training before surgery is only effective on mental health

Pre-operative high intensity interval training is effective and safe in deconditioned patients with lung cancer: A randomised clinical trial

(Randomised clinical trial)

[42]

• Exercise

Not based on a model or theory, but research that HIIT has shown to be feasible

and safe in deconditioned patients with chronic heart

disease and this could be replicated in patients awaiting primary lung resection surgery for NSCLC

HIIT exercise program Respiratory physiotherapists Supervised group sessions using a cycle ergometer Information not provided 3 weeks prior to surgery; 30 min 1–3 times a week If patients were unable to complete sessions at 100% power, the power was lowered according to the patients capacity to obtain a dyspnoea and leg fatigue of at least 5 on the Borg scale. Power was increased again if dyspnoea or the sense of effort decreased below 5. Work rate was adjusted each session as Borg ratings and heart rate evolved

Median duration between clinical decision and surgery was 25 days, which allowed a median of 8 high-intensity interval training sessions to be performed over 3 weeks. Adherence was 87%. Although 30% had COPD the training was well tolerated, indicating

the possibility of its regular application in pulmonary rehabilitation programmes

Two week multimodal prehabilitation program improves perioperative functional capability in patients undergoing thoracoscopic lobectomy for lung cancer: A randomised controlled trial

(Randomised controlled trial)

[43]

• Exercise

• Nutrition

• Wellbeing

No model or theory base reported

Exercise: Moderate intensity aerobic training, resistance exercises and respiratory training

Nutrition: Nutritional counselling with whey protein supplementation

Wellbeing: Mental relaxation including imagery and visualisation with relaxing music

Exercise: A doctor of physical therapy undertook all baseline assessments

Nutrition: Information not provided

Wellbeing: Information not provided

Exercise: Intensity based on the rate of perceived exertion (Borg scale) and target heart rate and set to achieve moderate training. Patients given an elastic resistance band to match their fitness level

Nutrition: 3 day total food recall questionnaire

Patients advised to change unhealthy eating habits, avoid high-calorie and high fat diets, eat more vegetables and fruits and high-quality proteins. Whey protein powder given to patients to take within one hour after exercise to achieve an intake of 1.5 g/kg/d of protein

Wellbeing: A music player with relaxing music was provided

Home based

Immediately after baseline visit (2 weeks before surgery)

Exercise: Aerobic exercise; 30 min 3 × week + resistance exercises 2 × week

Wellbeing: Daily prior to sleeping

Exercise: Tailored to patients fitness level

Nutrition: Advice given based on a 3-day total food recall questionnaire

Wellbeing: Information not provided

Improvement in 6MWD, but no differences in lung function, disability, psychological assessment, length of stay, short-term recovery quality, postoperative complications,

and mortality

Precision-Exercise-Prescription in patients with lung cancer undergoing surgery: Rationale and design of the PEP study trial (Randomised controlled trial protocol)

[44]

• Exercise

• Wellbeing

The wellbeing component is based on motivational interviewing and the social cognitive theory

Intervention arm:

Exercise: Consists of 5 stages: (1) Basic transfer mobility exercise (low-moderate intensity), (2) callisthenic mobility exercise (moderate-high intensity), (3) aerobic and resistance exercise (low-moderate intensity), (4) aerobic and resistance exercise (moderate intensity), (5) aerobic and resistance exercise (high intensity)

Wellbeing: Motivational and problem solving telephone calls

Control arm: Patients will be encouraged to increase walking both in the pre surgery and post-surgery period as part of usual clinical care, but there will be no formalised exercise programme

A physical therapist

Exercise: Instructional exercise sheets will be given to patients demonstrating exercise modes and intensity. Patients will be given access to light weights and resistance bands, an exercise diary and an activity tracker

Wellbeing: Motivational interviewing techniques, identification of barriers to exercising and problem-solving solutions, goal setting and self-monitoring

Either at home, the wellness centre or a recreational centre

Pre-surgery up to 6 months post-surgery. Exercise: Stages 1 and 2: Low intensity = 30 s-1 min 2 × day. Moderate intensity = 1–13 min 2 × day. High intensity = 1.5–2 min 4 × day

Stages 3, 4 and 5: Low intensity = 10 min of aerobic exercise + 5 min of resistance exercise. Moderate intensity = 20 min of aerobic exercise + 10 min of resistance exercise. High intensity = 30 min of aerobic exercise + 15 min of resistance exercise

Wellbeing: Weekly

Exercise: Based on an individual’s Activity Measure for Post Acute Care (AM-PAC) outpatient basic mobility score. It can be adjusted depending on a patients level of fatigue, muscle weakness, pain and/or shortness of breath

Wellbeing: Based on motivation and self-efficacy to engage in exercise

The following will be measured at baseline, on discharge, 2 months post-surgery and at 6 months post-surgery: AM-PAC mobility score, physical function (6MWD), strength, endurance and balance (short physical performance battery), patient-reported outcomes (functional assessment of cancer therapy-lung and chronic illness therapy-fatigue, Pittsburgh sleep quality index, physical activity, nutrition and wellbeing markers, subjective social status ladders, symptoms, living condition), exercise diary, length of stay, complications, healthcare costs and smoking assessment (saliva)

A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer (Randomised cross over study)

[45]

• Exercise

No model or theory base reported

Medical Qigong consisted of “Walking Qigong”. A walking exercise programme involving coordinated arm movements while in a state of deep relaxation or meditation. Patients were advised to refrain from independent resistance or cardiovascular training during this period

Standard exercise therapy: Consisted of cardiovascular and resistance training exercises. No details provided re: type of exercises. Patients were also advised to walk daily and to refrain from practising Qigong

A physiotherapist. Patients were also evaluated by a second physiotherapist (not involved in training and blinded to group assignment) at three time points: baseline 0–2 weeks

before starting the training periods, up to 2 weeks after

completing the first arm of the study and up to 2 weeks after completing the second arm

Medical Qigong and standard exercise therapy were delivered over a 6-week period. Patients stopped for a minimum of 2 weeks and then attended for a further 6 weeks to receive the other type of intervention

Medical Qigong was delivered as group sessions whereas standard exercise therapy was delivered either individually or as a group

Patients kept

logbooks of physical activities performed at home during both 6-week training periods

At the local hospital and at home

Over a 6 week period. Medical Qigong: 12 × 45 min face to face sessions + 1 h a day at home

Standard exercise therapy: Tailored to the individual + one hour of walking daily

Tailored to a patient’s individual training intensity

51 patients consented. 36 (71%) completed baseline assessment, 24 (47%) completed the first assessment after the first exercise intervention, but only 19 (37%) completed both exercise interventions and all assessments

In all cases, the beneficial effects of the exercise interventions were markedly reduced during the second interval. The order in which the interventions were performed had a significant impact on the improvement in certain symptoms

Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomised controlled trial (Randomised controlled trial)

[46]

• Exercise

• Wellbeing

Based on the theory of planned behaviour

Intervention arm: A physical activity and behavioural support programme incorporating aerobic physical activity, advice about resistance exercises and behavioural support sessions. Control arm: Patients received cancer-specific education materials regarding nutrition and exercise A physical activity consultant

Exercise: One to one supervised sessions + unsupervised home physical activity sessions

The behaviour support sessions use behaviour lifestyle change principles. Patients were also given a physical activity and behaviour change guidebook to use throughout the intervention

Information not provided

For 2 months

Exercise: Weekly; 30–45 min

Wellbeing: Weekly; 15–30 min behaviour support sessions

Exercise: Tailored to the patient’s baseline fitness, performance status and physical activity preferences

Wellbeing: Information not provided

Both groups reported more baseline physical activity than anticipated and symptoms and physical function did not deteriorate greatly over time

No significant differences between the two groups in terms of fatigue or QOL. Intervention adherence was good, with 69% completing all physical activity and 75% all behavioural change sessions. Attrition occurred in both groups, mainly due to disease progression

Preoperative exercise training

prevents functional decline after lung resection surgery: A randomised, single-blind

controlled trial (Randomised controlled trial)

[47]

• Exercise

No model or theory base reported

Preoperative exercise training consisted of a combination of moderate endurance and resistance training. Patients were also asked to perform breathing exercises Physiotherapist

Endurance training: On a cycle ergometer

At the beginning and end of the training, dyspnoea and leg fatigue were logged using the modified version of the Borg Scale

Resistance training: Using elastic bands and body weight exercises

Breathing exercises: Using a volume-oriented incentive spirometer

Hospital based 3–5 times a week depending on the surgical date

Endurance training load was determined after a symptom-limited incremental cycle test

Resistance training load was determined using a 25-maximum repetition test

Out of the 40 patients who were randomised, only 22 (55%) completed at least one postoperative evaluation and were analysed. In the prehabilitation group, mean time from baseline assessment to surgery was 54.5 days with a median of 16 sessions. Patients in the prehabilitation group were able to maintain and/or increase their baseline values in all the parameters examined, whereas in the control group there was a progressive decline throughout follow-up, especially in exercise capacity

Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: A randomised controlled study (Randomised controlled trial)

[48]

• Exercise

No model or theory base reported

HITT training program. Patients in both the intervention arm and the control group were given advice regarding active mobilisation and risk factor management (e.g., healthy nutrition and smoking and alcohol cessation) Physiotherapist Using a cycle ergometer Hospital based Pre-operatively 3 × week The work rate was adjusted on each session according to an individual’s maximal heart rate Short-term preoperative rehabilitation with HIIT did not improve pulmonary function and aerobic capacity measured at 1 year after lung cancer resection

Short-term Preoperative High-Intensity Interval

Training in patients awaiting lung cancer surgery: A randomised controlled trial (Randomised controlled trial)

[49]

• Exercise

No model or theory base reported

HITT training program. Patients in both the intervention arm and the control group were given advice regarding active mobilisation and risk factor management (e.g., healthy nutrition and smoking and alcohol cessation) Physiotherapist Using a cycle ergometer Hospital based in an outpatient clinic Pre-operatively 3 × week The work rate was adjusted on each session according to an individual’s maximal heart rate A HIIT programme helps prepare patients before lung cancer resection by enhancing their physical fitness. However, the HIIT programme did not improve postoperative clinical outcomes

Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomised study (A prospective randomised study)

[50]

• Nutrition

No model or theory base reported

Patients were given an immune modulating formulae (enriched with arginine, omega-3 fatty acids and nucleotides) for 10 days Information not provided Information not provided Information not provided Information not provided Information not provided Statistically significant difference in complication rates, mean tube drainage times and in drop in albumin levels in the intervention arm compared to the control group

Effect of prehabilitation on ventilatory efficiency in

non–small cell lung cancer patients: A cohort study (Cohort study)

[51]

• Exercise

Not based on a model or theory, but based on research that pulmonary prehabilitation improves

postoperative risk factors and ventilatory inefficiency

 > 35 is a high risk factor for postoperative complications

Endurance training, peripheral and inspiratory muscle strengthening Information not provided Endurance training: Via a cycle ergometer or a treadmill. Peripheral muscle strengthening: Information not provided. Inspiratory muscle strengthening: Using a threshold valve Patients were also taught bronchial drainage techniques and directed coughing In an ambulatory setting Prior to surgery. Endurance training and peripheral muscle strengthening: 90 min 3–5 × week. Inspiratory muscle strengthening: 15 min daily Load / intensity / resistance increased according to individual tolerance Prehabilitation did not change ventilatory efficiency. 15 or more sessions of prehabilitation seems to be a rational threshold to improve other CPET outcomes, while remaining applicable in clinical practice

Impact of prehabilitation on morbidity and mortality after pulmonary lobectomy by minimally invasive surgery: A cohort study (Cohort study)

[52]

• Exercise

No model or theory base reported

Endurance exercise, muscular strengthening and inspiratory muscle strengthening Two physiotherapists

Endurance exercise and muscle strengthening was performed on a cycle ergometer

Inspiratory muscle strengthening was performed using a resistive valve

Hospital based Pre-operatively: 90 min 3–5 × week Endurance exercise was tailored to an individual’s ventilator threshold Although significant differences were observed in the prehabilitation group in terms of a reduction in post-operative complications and Clavien-Dindo classification, no significant differences were seen in length of stay and severity of complications between groups

Application and practice of trimodal prehabilitation model in preoperative management of patients with lung cancer undergoing video-assisted thoracoscopic surgery (Prospective study)

[53]

• Exercise

• Nutrition

• Wellbeing

No model or theory base reported

Exercise: Aerobic exercise and stair-climbing training. Deep breathing training and abdominal breathing exercise. Nutrition: Whey protein supplement drink 1 h after exercise

Wellbeing: Relaxation training

Nursing staff

Dietitian

Exercise: Information not provided

Nutrition: Using the Nutrition Risk Screening tool. Wellbeing: Using a professional scale to evaluate psychological state and via relaxation training

Information not provided

Exercise: Aerobic exercise: 30 min 2 × day. Stair climbing: 2 × day Deep breathing training and abdominal breathing exercise: 10–15 min 3 × day. When the perceived fatigue was heavy, the exercise intensity was reduced

Nutrition: Information not provided

Wellbeing: 20 min daily

The intervention ended after the first

week of the operation

Nutritional input was tailored to the individual based on the Nutrition Risk Screening tool

No information provided for exercise and wellbeing

The application of a trimodal prehabilitation

model for the preoperative management of patients with lung cancer undergoing video-assisted thoracoscopic surgery is conducive to improving the functional state and psychological state, preventing complications and improving nursing satisfaction

Pre-treatment optimisation with pulmonary rehabilitation in lung cancer: Making the inoperable patients operable (Prospective observational study)

[54]

• Exercise

Not based on a model or theory, but on the hypothesis that older patients may have frailty and smoking related cardiopulmonary disease with reduced pulmonary function, which could impair post-operative ventilatory function predisposing them to dyspnoea, cardiopulmonary complications and death. Patients with significant

dyspnoea, poor performance status or poor pulmonary

function are considered in-operable

Comprised of four main elements

(1) Respiratory muscle training and breathing exercises (2) Cardiovascular exercises

(3) Education—Health education and smoking cessation advice

(4) Pharmacology agents—Where necessary bronchodilator therapy was provided

Trained cardiothoracic physiotherapists Information not provided At the prehabilitation centre or outreach unit and home based Over 2–4 weeks. 70 min face to face sessions with cardiovascular exercises 2 × week + home based respiratory muscle training and breathing exercises 3 × day

Individual training zones were calculated for the cardio-vascular exercises. Exercise intensity was based on the

rate of perceived exertion (Borg scale) and target heart rate

Following optimisation with prehabilitation, 84.2% of the high-risk patients were ready to proceed with radical treatment. 42.8% of patients underwent surgery

No significant differences in post-operative complications, length of hospital stay or mortality between the low and high risk groups

Neoadjuvant prehabilitation therapy for locally advanced non–small-cell lung cancer: Optimising outcomes throughout the trajectory of care (Retrospective study)

[55]

• Exercise

• Nutrition

• Wellbeing

No model or theory base reported

Exercise: Moderate-vigorous intensity aerobic training and resistance training

Nutrition: Patients screened using validated tools, advised to aim for 1.5 g/kg/d of protein and prescribed whey protein supplements if required

Wellbeing: Relaxation exercises based on imagery, visualisation and deep breathing to help reduce anxiety

Exercise:

Certified kinesiologist

Nutrition: Dietitian

Wellbeing: Psychology trained personnel

Exercise: According to a patient’s preferred type of aerobic training

Nutrition: All patients screened using the PG-SGA and the Nutritional Risk Screening tool. Daily protein calculated at 1.5 g/kg ideal body weight

Wellbeing: A compact disc with relaxation exercises provided

Home-based unsupervised programme

Immediately after baseline assessment (approximately four weeks prior to surgery) and up to eight weeks after surgery. Exercise: 30 min 3 × week + resistance training 3 × week Nutrition: 1.5 g/kg ideal body weight of protein per day + protein supplements within 1 h of exercise

Wellbeing: 2–3 × week

Exercise: Tailored to a patient’s preferred type of exercise and fitness level

Nutrition: Advice given based on a 3 day food diary completed at the time of enrolment

Wellbeing: Information not provided

The prehabilitation programme was individualised and home-based, which allowed patients to complete the programme at home at any convenient time, simplifying the already demanding schedule of a patient undergoing neoadjuvant therapy. Only 1 patient dropped out after initiation of the prehabilitation programme, demonstrating good feasibility

Malnourished lung cancer patients have poor baseline functional capacity but show greatest improvements with multimodal prehabilitation

(Retrospective study)

[56]

• Exercise

• Nutrition

• Wellbeing

No model or theory base reported

Exercise: The home-based training included moderate intensity aerobic training, resistance exercises and flexibility exercises

Nutrition: Individualised plan to meet each patients nutritional needs + whey protein supplementation to achieve a total protein intake of 1.2–1.5 g/kg/d

Wellbeing: Patients given techniques aimed at reducing anxiety, such as relaxation exercises based on imagery, visualisation and deep-breathing exercises

Exercise: Kinesiologist

Nutrition: Dietitian

Wellbeing: Psychology trained personnel

Exercise: Patients provided with an information booklet with instructions and figures on all elements of the program and exercise progressions. The booklet also included a journal to record all activities related to the program. Nutrition: A comprehensive dietary assessment based on a 3-day food diary, anthropometry, nutrition impact symptoms, biochemistry and a nutrition focused physical exam. Instructions included eating well-balanced meals with a focus on protein intake. Wellbeing: One to one sessions and a compact disc with relaxation exercises for home Hospital based combined with unsupervised exercise sessions at home

4 weeks prior to surgery. Exercise: 30 min 5 × week

Nutrition: Information not provided

Wellbeing: 2–3 × week

Exercise: Individualised based upon initial assessments

Nutrition: Individualised dietary advice

Wellbeing: Tailored according to a patients needs

Patients

classified with moderate or high nutrition risk (according to the PG-SGA) exhibited significantly lower physical performance at baseline, including functional capacity, timed get up and go, grip strength and self-reported physical activity levels compared with low-nutrition-risk patients. High nutrition risk patients have the most to gain (functionally) from multimodal prehabilitation compared with low nutrition risk patients

Feasibility and outcomes of a real-world regional lung cancer prehabilitation programme in the UK

(Feasibility study)

[57]

• Exercise

• Nutrition

• Wellbeing

Based on the principles of NHS England’s Personalised Care model

Exercise: All patients triaged into ‘universal’ or ‘targeted’ pathways. For the universal pathway, patients could exercise independently with weekly monitoring with an exercise specialist. Exercise prescriptions included high-intensity interval training and resistance training

Nutrition and wellbeing: Assessed at baseline and at intervals throughout the programme. A three-tier risk assessment (low, medium and high) was used to identify those in need of nutritional or wellbeing support and each category received simple interventions or onward referral when required

Exercise specialists (level four cancer rehabilitation qualified exercise practitioners) were responsible for screening patients and delivering all components of the intervention Patients initially contacted by telephone to organise a face-to-face appointment at a first assessment clinic. Baseline assessments took place face-to-face and an individualised programme was prescribed Patients could complete their individualised programme at any one of the 87 local leisure centres

Exercise prescriptions for the targeted pathway included 3 supervised group gym sessions x

No information is provided on the length of the prehabilitation period. Baseline functional and QOL assessments were repeated immediately before the date of surgery

After treatment, a 12 week postoperative rehabilitation programme was provided

Individualised prehabilitation programme prescription for all tri modal components

Of the 377 patients referred, overall participation on an intention to treat basis was 47.7%. Median interval from assessment to surgery was 36 days. There were no adverse events. Statistically significant improvements in the Incremental Shuttle Walk Test (ISWT), 6MWT, 60 min sit to stand test (STS), Hand Grip Dynamometry (HGD), World Health Organisation Disability Assessment Scheduled (WHODAS), Self-Efficacy for Exercise (SEE), International Physical Activity Questionnaire (IPAQ), and the European Quality of Life

Five Dimensions (EQ-5D) scores

Feasibility of setting up a pre-operative optimisation ‘prehab’ service for lung cancer surgery in the UK

(Feasibility study)

[58]

• Exercise

Not based on a model or theory, but based on the hypothesis that respiratory function could be improved by optimising treatment for

comorbidities, potentially tipping the balance between a patient being deemed not fit enough for surgery and being considered a surgical candidate

The prehabilitation programme was based around the mainstays of COPD management: optimising inhaled therapy, smoking cessation and pulmonary rehabilitation (including progressive muscle resistance and aerobic training) Oncology outpatient physiotherapy team, local community respiratory team or cardio-respiratory physiotherapy team depending on patient choice, need and availability Information not provided One-to-one or group sessions depending on patient choice, need and availability Referral was made as early as possible. For the majority of patients, the duration was driven by the pragmatic constraints of the 62-day lung cancer pathway. The pragmatic approach around location, nature and duration of programme led to significant variation in the nature of individual patients programmes Tailored according to patient choice, need and availability

Median number of sessions for 35 patients seen purely by the outpatient oncology physiotherapy team was three over a median of 22 days. Eight patients (16%) underwent inpatient prehabilitation, with a median duration of eight days. This variance was predominantly driven by the scheduled surgical date. 13 patients (26%) were unnecessary or inappropriate referrals

Improvement in surgical rates from 12.8% at the inception of the study to 29.8% at the end

A feasibility study of an unsupervised, pre-operative exercise program for adults with lung cancer (Feasibility study)

[59]

• Exercise

No model or theory base reported

Patients received a verbal and written exercise prescription from their surgeon:

“Do any moderately-intense aerobic physical activity (e.g., walking, jogging, stair climbing, upper body ergometer, stationary bicycle) for 30 min a day and for 5 days each week. While doing the activity, you should be working hard enough that it is difficult to speak more than a few words at a time. You may need to start slowly (e.g., 5–10 min at a time), but as you get stronger you can increase your activity so that you exercise for 30 min at a time.”

Surgeon and a project co-ordinator

Each patient was given a Garmin Vivoactive heart rate device. Patients were assigned an email address and password

which was used as a login for the Garmin Connect

Mobile App. The project coordinator downloaded the application onto patient phones and activated the fitness device during enrolment Patients were asked to synchronise and charge the device daily and wear the device at all other times including showering and sleeping

Patients recorded their aerobic exercise sessions within a paper-based log

Home based Pre-operatively 30 min 5 × week Patients were allowed to choose the type of activity that they found most feasible or enjoyable

81% recruitment rate with 79% completing the pre-operative assessments. Only

29% completed the exercise log and 14% experience adverse events related to the device

79% reported at least one aspect of the fitness device that they disliked and 29% reported at least one thing they did not understand regarding the device

Pre-radiotherapy daily exercise training in non-small cell lung cancer: A feasibility study

(Feasibility study)

[60]

• Exercise

No model or theory base reported

Structured exercise training immediately prior to radiotherapy. This consisted of three exercise phases. Phase one and three: interval training. Phase two: continuous cycling An exercise physiologist or physiotherapist Supervised, individualised exercise using an ergometer cycle. All patients wore heart rate monitors during the exercise sessions and were given Garmin® vívosmart® heart rate activity trackers to use during the course of radiotherapy Next to the accelerator when a patient attended for radiotherapy treatment The intervention period was equal to the patient’s number of radiotherapy sessions over a seven week period, with each session lasting 20 min The exercise sessions were tailored to the patient’s fitness level

The intervention comprised of 31 prescribed exercise sessions over the seven-week period. Overall attendance rate to exercise was 90%. Of the 90% attendance, the adherence rate to full exercise participation was 88.1% and was performed by a modified program due to early exhaustion, pause during the exercise session or practical reasons (e.g. earlier start of radiotherapy on a given day)

2 patients were hospitalised due to chemotherapy adverse events. No adverse events were observed during the exercise sessions

Patients’ and healthcare professionals’ views on a pre-and post-operative rehabilitation programme (SOLACE) for lung cancer: A qualitative study (Qualitative study)

[61]

• Exercise

• Nutrition

• Wellbeing

Not based on a model or theory, but based on a previous pre and post-surgical intervention study in pulmonary rehabilitation which demonstrated a reduction in post-operative complications and hospital readmissions

No specific information provided. Services provided in the SOLACE programme include patient education / written information on recovery from lung cancer surgery, smoking cessation, nutritional advice, information on thoracic surgical pathways, psychological support, pain management, financial help, links to other NHS, Macmillan and external support agencies, pre-and post-operative rehabilitation exercise classes, local exercise referrals and rehabilitation DVDs

A Macmillan lung cancer survivorship

Advanced Nurse Practitioner (ANP) and a Macmillan lung cancer survivorship

Advanced Therapist Practitioner (ATP)

Through the provision of personalised support depending on a patient’s support requirements, Interventions informed by the Macmillan guidance Hospital and/or community based Information not provided Provision of personalised support

Pre and post-operative rehabilitation services can help improve patients’ perceived physical and psychological health and build self-confidence in their ability to self-manage

There is a need to consider ways to enable prolonged access to rehabilitation services for lung cancer patients entering the follow-up stages of their care

Attitudes and perceptions to prehabilitation in lung cancer (Online cross-sectional survey)

[62]

• Exercise

No model or theory base reported

24 item survey sent to 198 fellows of the Royal

Australasian College of Cardiothoracic Surgeons

Information not provided Via email, college newsletters, digital press and in printed format Throughout Australia and New Zealand Information not provided Information not provided

 > 90% of cardio-thoracic surgeons surveyed would delay surgery for prehabilitation in order to optimise ‘high risk’ patients (those with multiple comorbidities, advanced age, positive smoking status / respiratory disease, and/or obesity) preoperatively, particularly in patients with borderline fitness for surgery. The main barriers to prehabilitation reported were patient

comorbidities and access to allied health professionals

Potential effectiveness of a surgeon-delivered exercise prescription and an activity tracker on pre-operative exercise adherence and aerobic capacity of lung cancer patients (Proof of concept study)

[63]

• Exercise

Not based on a model or theory, but based on the hypothesis that pre-operative exercise can improve functional outcomes for lung cancer patients, but barriers associated with cost, resources, and burden make it challenging to deliver pre-operative exercise programs

Patients received a verbal and written exercise prescription from their surgeon:

“Do any moderately-intense aerobic physical activity (e.g., walking, jogging, stair climbing, upper body ergometer, stationary bicycle) for 30 min a day and for 5 days each week. While doing the activity, you should be working hard enough that it is difficult to speak more than a few words at a time. You may need to start slowly (e.g., 5–10 min at a time), but as you get stronger you can increase your activity so that you exercise for 30 min at a time.”

Surgeon and a project co-ordinator

The project co-ordinator provided a written copy of the prescription on enrolment. Each patient was given a Garmin Vivoactive heart rate device. Patients were assigned an email address and password which was used as a login for the Garmin Connect

Mobile App. The project coordinator downloaded the application onto patient phones and activated the fitness device during enrolment. Patients were asked to synchronise and charge the device daily and wear the device at all other times including showering and sleeping

Home based Pre-operatively 30 min 5 × week Patients were allowed to choose the type of activity that they found most feasible or enjoyable Proof of concept was achieved as nearly half of the study sample achieved the minimal clinically meaningful improvement in aerobic capacity prior to surgery as a result of participation in the intervention. However, approximately 50% did not achieve this and the majority of patients fell short of achieving the prescribed weekly MVPA goal. Future work should involve the use of a triage system to identify patients who can successfully adhere to the pre-operative exercise prescription with only “low-touch” support and those who could benefit from additional resources and high-touch forms of support

Prehabilitation in thoracic cancer surgery: From research to standard of care (Quality Improvement Project)

[64]

• Exercise

• Nutrition

• Wellbeing

No model or theory base reported

The prehabilitation program included 3 steps: (1) Screening, (2) Assessment and (3) Intervention. Screening identified high-risk patients with at least one functional, nutritional, or psychological impairment. Assessment quantified the severity of the impairment to help tailor the intervention. The intervention was tailored based on specific physical, nutritional, or psychological impairments identified during the assessment phase. High-risk patients with a mild impairment received a low-intensity prehabilitation program, whereas high-risk patients with severe impairments were given a high-intensity prehabilitation program

Exercise: Kinesiologist

Nutrition: Dietitian

Wellbeing: Nurse specialist with specific training in psycho-social support for patients with cancer

Exercise: Screening—6MWT and the Duke Activity Status Index (DASI). Assessment—CPET

Nutrition: Screening—Involuntary weight loss > 10% in 6 months and/or reduced dietary intake < 50% over the previous weeks and/or nutrition related symptoms (poor appetite, dysphagia, vomiting or and constipation over the last weeks) and/or low handgrip strength: < 20th percentile of normative value. Assessment: PG-SGA

Wellbeing: HADS questionnaire

Hospital based Information not provided All interventions were tailored to each individual

58 patients showed at least one or more physical, nutritional, or mental impairment and progressed onto the assessment phase of the program. 23 patients were categorised as low risk. 45 high-risk patients received a one-month personalised prehabilitation program. 16 of these received a trimodal program and 22 received a nutrition and exercise program

The median duration of prehabilitation was 30 days

Overview of the studies

The 31 studies included in this review comprised of fourteen randomised controlled trials [3436, 38, 4043, 4550], four feasibility studies [5760], three registered protocols [37, 39, 44], two cohort studies [51, 52], two prospective studies [53, 54], two retrospective studies [55, 56], one qualitative study [61], one cross sectional survey [62], one proof of concept study [63] and one quality improvement study [64].

The largest number of studies originated from Canada (n = 6). The origins of the other studies included France (n = 4), United Kingdom (n = 4), China (n = 3), Switzerland (n = 3), United States of America (n = 3), Australia (n = 2), Denmark (n = 2), Spain (n = 2), Ireland (n = 1) and Turkey (n = 1).

Sample sizes ranged from 15 to 377 lung cancer patients with a mean age range of 46 – 72 years of age.

How does the literature within the field of lung cancer describe the structure of prehabilitation?

All studies except one [50] included in this review featured an exercise component as part of a prehabilitation programme. Sixteen studies were uni-modal, focusing solely on exercise prehabilitation [38, 4042, 45, 4749, 52, 54, 5860, 62, 63]. Ten out of the 31 studies described multimodal prehabilitation interventions using a tri-modal approach, incorporating nutrition, exercise and psychological wellbeing [35, 36, 39, 43, 53, 5557, 61, 64]. Other studies incorporated an exercise and psychological component (n = 3) [34, 44, 46] or an exercise and nutrition component (n = 1) [37]. A single study focused solely on nutrition prehabilitation [50], but there were no uni-modal psychological wellbeing prehabilitation intervention studies. See Table 3.

All prehabilitation interventions varied in terms of programme setting, type of intervention, patient criteria, intervention delivery, duration of prehabilitation and measured outcomes. Nine out of the 31 studies provided a comprehensive description of all aspects of the prehabilitation programme [36, 40, 44, 45, 47, 52, 59, 60, 63]. In relation to programme setting, most interventions were delivered in a hospital setting (n = 9) [37, 4749, 51, 52, 58, 60, 64] or provided flexibility between a hospital setting and remote supervision (n = 9) [36, 39, 40, 44, 45, 54, 56, 61, 62]. Six of the 31 studies used remote supervision [35, 43, 55, 57, 59, 63]. In the remaining studies, the programme setting was unclear (n = 7) [34, 38, 41, 42, 46, 50, 53].

Exercise

All prehabilitation programmes that included an exercise intervention used a baseline physical fitness assessment to develop an individualised exercise prescription. The type of baseline physical fitness assessment used was variable throughout all of the studies, ranging from cardio-pulmonary exercise testing to more general elements such as muscle strength and activity questionnaires. More than 50% of the studies described the exercise intervention as a combination of both aerobic and resistance exercise to improve cardiorespiratory fitness and muscle strength. Other exercise interventions included High Intensity Interval Training (HIIT) and medical Qigong. Breathing exercises such as Respiratory Muscle Endurance Training (RMET) were also described under the term exercise, alongside aerobic exercise interventions.

Nutrition

Tailored dietetic advice was provided in all prehabilitation programmes which included a nutritional component (n = 12) [3537, 39, 43, 50, 53, 5557, 61, 64]. In eight studies, this was based on an individualised assessment, which was undertaken by a registered dietitian [3537, 39, 53, 55, 56, 64]. Only three studies [35, 55, 64] stated using validated tools such as the Patient Generated Subjective Global Assessment (PG-SGA). However, the use of nutritional screening tools to assess malnutrition risk was not frequently described. The majority of studies (n = 8) [3537, 39, 43, 53, 55, 56] focused on increasing dietary protein, often recommending the use of protein supplements. Two interventions focused on the use of a fish oil supplement [36, 50].

Psychological wellbeing

Only three studies described the validated tools that were used to establish baseline psychological wellbeing. These included the Hospital Anxiety and Depression Score (HADS) [53, 55] and the Short Form (SF) 36 questionnaire [47]. There was large variation in the description of the psychological interventions used. Some studies used the terms ‘support’ and ‘coping strategies’, whereas in other studies, more specific techniques such as relaxation, imagery, visualisation, cognitive behavioural therapy and motivational interviewing were described.

How does the literature within the field of lung cancer describe the personalisation of prehabilitation interventions?

A number of studies described tailoring the exercise, nutrition and/or psychological wellbeing prehabilitation intervention to an individual (n = 28), but there was large variation across all studies in how this was fully conceptualised and achieved. The personalisation of the prehabilitation intervention mostly referred to a starting point variation along a continuum, e.g. intensity of exercise in relation to baseline fitness. This was typically considered at a single point, usually at baseline and not reviewed.

Only two studies [44, 46] in this review reported using theory to underpin the design of this complex intervention. The two theories that were described were the theory of planned behaviour and social cognitive theory, respectively.

What are the actual outcomes for lung cancer patients participating in a prehabilitation programme?

Twenty-six out of the 31 studies included in this review focused on lung cancer surgery. The remaining studies included chemotherapy (n = 2) [38, 45], radiotherapy (n = 1) [60], neoadjuvant treatment (n = 1) [55] or had a specific focus on quality of life (n = 1) [46] for those with advanced lung cancer.

There was a wide variety of outcomes reported amongst all interventional studies. The majority of reported actual outcomes were positive. These included improvements in functional capacity (n = 16) [34, 4043, 45, 47, 49, 51, 53, 5558, 63, 64], high adherence to the intervention (n = 5) [36, 42, 57, 59, 60], improvements in psychological wellbeing (n = 3) [38, 53, 55], reductions in post-operative complications (n = 5) [40, 41, 50, 52, 53], improvements in muscle strength (n = 3) [38, 45, 47], no adverse events (n = 5) [34, 57, 58, 60, 64], qualitative outcomes including increased perceived physical and psychological health benefits (n = 2) [61, 62], reductions in length of hospital stay (n = 2) [41, 64] and improvements in quality of life (n = 1) [58]. Conversely, five studies reported no improvement in functional capacity [35, 36, 38, 46, 48]. Furthermore, some studies described no improvement in quality of life (n = 4) [36, 41, 45, 46], length of hospital stay (n = 5) [35, 43, 51, 52, 54], post-operative complications (n = 5) [43, 49, 51, 54, 64], survival (n = 3) [43, 46, 48] or psychological wellbeing (n = 2) [43, 45]. Only one study [59] reported an unintended outcome of their intervention which was related to an adverse reaction to the device used to monitor heart rate.

The intended outcomes described within the three protocol papers included in this review [37, 39, 44] are similar to the actual outcomes reported from the interventional studies as shown above. These include improvements in functional capacity (n = 2) [37, 44], improvements in quality of life (n = 2) [37, 44], reductions in hospital length of stay (n = 2) [39, 44], reductions in post-operative complications (n = 3) [37, 39, 44] and qualitative outcomes including self-efficacy (n = 1) [44]. All three randomised controlled trials for which protocols have been published [37, 39, 44] include health economics in their planned outcomes. These include treatment related costs as well as costs from a healthcare professional perspective. This will provide valuable information on the economic implication of the adoption of prehabilitation programmes for patients with lung cancer.

Specific to the oncological lung cancer treatment pathway, a multi-modal prehabilitation programme delivered remotely during neoadjuvant treatment led to a significant improvement in functional capacity and psychological wellbeing [55]. In comparison, a uni-modal exercise prehabilitation intervention for 110 lung cancer patients with advanced inoperable lung cancer undergoing chemotherapy showed no significant difference in functional capacity. However, there were significant improvements in strength and psychological wellbeing [38]. Nevertheless, these results should be interpreted with caution owing to high attrition, poor adherence and anticipated attenuation of decline amongst this cohort.

Discussion

To our knowledge, this is the first scoping review that aims to summarise the evidence on prehabilitation in the lung cancer pathway using a realist approach.

Our review provides a summary of several interventional studies and three ongoing randomised controlled trials for which protocols have been published.

The majority of studies in this review had a surgical focus and demonstrated that prehabilitation before lung cancer surgery is feasible and is associated with physiological and psychological benefits. Our findings reveal that there are only a few studies involving lung cancer patients undergoing oncological treatment, despite 70–80% of people with lung cancer receiving non-surgical treatment within the UK [65].

Our analysis of the contexts, mechanisms and outcomes for prehabilitation provide useful insights into the factors that need to be considered in the design and implementation of prehabilitation for patients with lung cancer.

Prehabilitation is a complex intervention. It is widely understood that the success of a complex intervention depends on the theory underpinning its design [19], which helps to explain the mechanisms underlying an individual’s behaviour, based on what works for them and their circumstances [22]. However, only two studies in this review described using theory to underpin the design of this complex intervention [44, 46]. Similarly, there are only two completed studies which used a qualitative approach [61, 62], with only one evaluating the acceptability of their interventions, despite this being an important consideration for complex interventions [61, 66]. Although the qualitative literature in this field sheds some light on some of the factors which might influence engagement with prehabilitation, it does not fully illustrate the complexity of delivering prehabilitation.

Using a realist lens, this review has identified the importance of a personalised approach to prehabilitation. Whilst the personalisation of the prehabilitation intervention was often stated by the studies reviewed, and generally viewed as a positive factor, how it was fully conceptualised and achieved was less clear. The personalisation of the intervention mostly referred to a starting point variation along a continuum, e.g. intensity of exercise in relation to baseline fitness. No studies considered personalisation to patient-led values, needs, goals, support structures and beliefs. This is a considerable gap, given that initiation and adherence to any intervention is determined by behavioural, psychological, physiological, environmental and social factors [2023], especially when research findings with well-intentioned patients need to be translated to clinical practice with the full range of real-world complexities and comorbidities [23].

Personalisation was mostly considered at a single point, typically at baseline. This is typical in pre-surgical prehabilitation, where it is a relatively brief and linear process from baseline to a defined, one-off target (surgery). However, prehabilitation during oncological treatment is a prolonged and undulating 'marathon', during which the patients other roles, values and needs have to be considered with learning and adaptation along the journey. An adaptable model and practice of ongoing, collaborative personalisation therefore needs to be explicitly defined and implemented. To address this, future research could utilise the Adversity, Restoration and Compatibility (ARC) framework [21] to help underpin a personalised and collaborative prehabilitation programme. The ARC framework provides a synthesised view of how people conceptualise the personal experience of living with and beyond cancer, namely as an ongoing process of learning about their evolving challenge (Adversity), learning how to cope effectively (Restoration) and adapting one's identity (Compatibility), in parallel. These broad themes, derived from qualitative synthesis of over 70 primary studies of patient narratives, are consistent with psychological adjustment theory [67] and may provide a structure for personalising prehabilitation that is patient-centred rather than a purely logistical or psychometric approach. This could be key to empower patients to maintain progress through the longer, more variable context of peri-oncological prehabilitation. This theory-led approach is further supported by Faithfull et al., 2019 [5] and The Medical Research Council (MRC) framework for developing and evaluating complex interventions [68] which suggests that future studies should use a conceptual framework to help guide intervention design and thereby maximise outcomes.

We acknowledge the limitations of this review. Firstly, we recognise that some studies may have been missed by database searching or were published after the search date. Secondly, the extrapolation of findings is limited owing to context dependency e.g. it may be difficult to extrapolate the results from a pre-surgical setting to those with a poor prognosis. Thirdly, only a few studies included in this scoping review provided a comprehensive description of all aspects of the prehabilitation programme, therefore the descriptions of the interventions are limited. To counterbalance this, a realist framework of context, mechanism and outcome has been used for reporting. Furthermore, our analysis of the mechanisms and outcomes for prehabilitation provide insight into the role of prehabilitation within the lung cancer pathway.

The coronavirus pandemic has accelerated the remote delivery of prehabilitation interventions. Completed studies suggest that home-based multimodal prehabilitation is feasible and leads to improvements in a range of outcomes [43, 55, 57, 59, 63]. However, there is limited qualitative data in this field to determine whether remote delivery of prehabilitation interventions is more or less favourable than face to face or a hybrid approach.

There is potential for digital interventions within this field. Two completed studies in this review used an app for the delivery of their prehabilitation interventions [59, 63], with one study demonstrating high recruitment and attrition rates [59] and the other showing a minimally clinically meaningful improvement in aerobic capacity prior to surgery as a result of participation in the intervention [63]. However, it is important to note that in the latter study, approximately 50% did not achieve an improvement in aerobic capacity with the majority of patients falling short of achieving the prescribed weekly exercise target. Technology access, skillset and confidence strongly need to be considered prior to implementation of delivery of prehabilitation interventions [69]. Furthermore, the cost-effectiveness of a technology supported multimodal prehabilitation programme needs to be evaluated. The study by Barberan-Garcia et al. [39] aims to address this, as detailed in their published study protocol.

Whilst there will be emerging evidence from ongoing randomised controlled trials, the heterogeneity in study designs, programme setting, type of intervention, patient criteria, intervention delivery, duration of prehabilitation and measured outcomes is significant. There are no trials which have the same set of primary and secondary outcomes. The lack of standardisation across interventions and outcome measures makes it difficult to conclude benefit across the whole lung cancer pathway. The inability to draw significant improvement benefit of prehabilitation due to the heterogeneity of studies has also been seen in systematic reviews in breast cancer [70], pancreatic cancer [71] and hepatobiliary cancers [72].

Conclusion

This scoping review demonstrates that there is evidence for providing prehabilitation for patients with lung cancer, particularly in the surgical domain. However, there is a lack of clinical trials which provide definitive evidence on the programme design, setting, type of intervention, patient criteria, delivery and duration. This therefore makes it difficult to conclude significant improvement benefit.

The design and implementation of future lung cancer prehabilitation programmes should take into account factors such as patient led values, needs, goals, support structures and beliefs which can affect the delivery and engagement of interventions. The findings of this review provide important insights into these issues.

Furthermore, future research should consider the use of a conceptual framework such as ARC [21] to conceptualise the living with and beyond cancer experience to help shape and inform personalised prehabilitation services. This will enable personalised care to be given from the outset and help support identification of the ideal prehabilitation model and delivery options to optimise both health and economic outcomes. This will enable patient empowerment and engagement towards self-managed behaviours and thus, optimise long-term health.

Acknowledgements

The authors would like to acknowledge and thank Health Education England for the funding and support provided to undertake this scoping review.

Authors’ contributions

K.W-M: conceptualization, methodology, formal analysis, investigation, writing – original draft, writing – review and editing. A.K: methodology, writing – review and editing, supervision. C.U: methodology, supervision. J.J-J: supervision, funding acquisition. A.M: methodology. C.L: methodology, writing – review and editing. All authors have read and approved the final manuscript.

Funding

This review was supported by Health Education England through a Cancer Prehabilitation Service Transformation Fellowship. The funders were not involved in the data collection, analysis, interpretation and writing of the study.

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publications

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Cancer Research UK. Cancer Research UK. Lung cancer incidence statistics. 2016–2018. 2016 2018. Cited 2023 Mar 17. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/incidence#heading-Zero.
  • 2.Cancer Research UK. Cancer Research UK. Lung cancer mortality statistics 2017–2019. 2017 2019. Cited 2022 Oct 17. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer#heading-Five.
  • 3.Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115(9):1147–1155. doi: 10.1038/bjc.2016.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Silver JK, Baima J. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil. 2013;92(8):715–727. doi: 10.1097/PHM.0b013e31829b4afe. [DOI] [PubMed] [Google Scholar]
  • 5.Faithfull S, Turner L, Poole K, Joy M, Manders R, Weprin J, et al. Prehabilitation for adults diagnosed with cancer: A systematic review of long‐term physical function, nutrition and patient‐reported outcomes. Eur J Cancer Care (Engl). 2019;28(4). Cited 2021 Oct 27. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ecc.13023. [DOI] [PubMed]
  • 6.Boereboom C, Doleman B, Lund JN, Williams JP. Systematic review of pre-operative exercise in colorectal cancer patients. Tech Coloproctology. 2016;20(2):81–89. doi: 10.1007/s10151-015-1407-1. [DOI] [PubMed] [Google Scholar]
  • 7.Carli F, Gillis C, Scheede-Bergdahl C. Promoting a culture of prehabilitation for the surgical cancer patient. Acta Oncol. 2017;56(2):128–133. doi: 10.1080/0284186X.2016.1266081. [DOI] [PubMed] [Google Scholar]
  • 8.Barberan-Garcia A, Ubré M, Roca J, Lacy AM, Burgos F, Risco R, et al. Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial. Ann Surg. 2018;267(1):50–56. doi: 10.1097/SLA.0000000000002293. [DOI] [PubMed] [Google Scholar]
  • 9.Piraux E, Caty G, Reychler G. Effects of preoperative combined aerobic and resistance exercise training in cancer patients undergoing tumour resection surgery: a systematic review of randomised trials. Surg Oncol. 2018;27(3):584–594. doi: 10.1016/j.suronc.2018.07.007. [DOI] [PubMed] [Google Scholar]
  • 10.Doganay E, Moorthy K. Prehabilitation for esophagectomy. J Thorac Dis. 2019;11(S5):S632–S638. doi: 10.21037/jtd.2019.02.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.van Rooijen SJ, Molenaar CJL, Schep G, van Lieshout RHMA, Beijer S, Dubbers R, et al. Making patients fit for surgery: introducing a four pillar multimodal prehabilitation program in colorectal cancer. Am J Phys Med Rehabil. 2019;98(10):888–896. doi: 10.1097/PHM.0000000000001221. [DOI] [PubMed] [Google Scholar]
  • 12.Fulop A, Lakatos L, Susztak N, Szijarto A, Banky B. The effect of trimodal prehabilitation on the physical and psychological health of patients undergoing colorectal surgery: a randomised clinical trial. Anaesthesia. 2021;76(1):82–90. doi: 10.1111/anae.15215. [DOI] [PubMed] [Google Scholar]
  • 13.Waterland JL, Chahal R, Ismail H, Sinton C, Riedel B, Francis JJ, et al. Implementing a telehealth prehabilitation education session for patients preparing for major cancer surgery. BMC Health Serv Res. 2021;21(1):443. doi: 10.1186/s12913-021-06437-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bradley P, Merchant Z, Rowlinson-Groves K, Taylor M, Moore J, Evison M. Feasibility and outcomes of a real-world regional lung cancer prehabilitation programme in the UK. Br J Anaesth. 2023;130(1):e47–55. doi: 10.1016/j.bja.2022.05.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Treanor C, Kyaw T, Donnelly M. An international review and meta-analysis of prehabilitation compared to usual care for cancer patients. J Cancer Surviv. 2018;12(1):64–73. doi: 10.1007/s11764-017-0645-9. [DOI] [PubMed] [Google Scholar]
  • 16.Chmelo J, Navidi M, Sinclair RC, Greystoke A, Phillips AW. 522 Can prehabilitation improve health-related quality of life of patients during Neoadjuvant chemotherapy for Esophagogastric adenocarcinoma? Dis Esophagus. 2022;35(Supplement_2):doac051.522. [Google Scholar]
  • 17.Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, et al. Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology. 2018;155(2):391–410.e4. doi: 10.1053/j.gastro.2018.05.012. [DOI] [PubMed] [Google Scholar]
  • 18.Cancer Research UK. Cancer Research UK. Cancer treatment statistics 2013–2016. 2013 2016. Cited 2022 Oct 3. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/treatment.
  • 19.Dhiman A, Ray MD. Enhanced recovery after gynecological/oncological surgeries: current status in India. Indian J Gynecol Oncol. 2020;18(4):127. [Google Scholar]
  • 20.Ferreira V, Agnihotram RV, Bergdahl A, van Rooijen SJ, Awasthi R, Carli F, et al. Maximizing patient adherence to prehabilitation: what do the patients say? Support Care Cancer. 2018;26(8):2717–2723. doi: 10.1007/s00520-018-4109-1. [DOI] [PubMed] [Google Scholar]
  • 21.Le Boutillier C, Archer S, Barry C, King A, Mansfield L, Urch C. Conceptual framework for living with and beyond cancer: A systematic review and narrative synthesis. Psychooncology. 2019;28(5):948–959. doi: 10.1002/pon.5046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bhandoria G, Solanki SL, Bhavsar M, Balakrishnan K, Bapuji C, Bhorkar N, et al. Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey. Pleura Peritoneum. 2021;6(3):99–111. doi: 10.1515/pp-2021-0117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Grimmett C, Bradbury K, Dalton SO, Fecher-Jones I, Hoedjes M, Varkonyi-Sepp J, et al. The Role of behavioral science in personalized multimodal prehabilitation in cancer. Front Psychol. 2021;12:261. doi: 10.3389/fpsyg.2021.634223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bayly J, Edwards BM, Peat N, Warwick G, Hennig IM, Arora A, et al. Developing an integrated rehabilitation model for thoracic cancer services: views of patients, informal carers and clinicians. Pilot Feasibility Stud. 2018;4(1):160. doi: 10.1186/s40814-018-0350-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bayly J, Fettes L, Douglas E, Teixiera MJ, Peat N, Tunnard I, et al. Short-term integrated rehabilitation for people with newly diagnosed thoracic cancer: a multi-centre randomized controlled feasibility trial. Clin Rehabil. 2020;34(2):205–219. doi: 10.1177/0269215519888794. [DOI] [PubMed] [Google Scholar]
  • 26.Rycroft-Malone J, McCormack B, Hutchinson AM, DeCorby K, Bucknall TK, Kent B, et al. Realist synthesis: illustrating the method for implementation research. Implement Sci. 2012;7(1):33. doi: 10.1186/1748-5908-7-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R. RAMESES publication standards: realist syntheses. BMC Med. 2013;11(1):21. doi: 10.1186/1741-7015-11-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–473. doi: 10.7326/M18-0850. [DOI] [PubMed] [Google Scholar]
  • 29.Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119–2126. doi: 10.11124/JBIES-20-00167. [DOI] [PubMed] [Google Scholar]
  • 30.Silver J. Cancer prehabilitation and its role in improving health outcomes and reducing health care costs. Semin Oncol Nurs. 2015;31(1):13–30. doi: 10.1016/j.soncn.2014.11.003. [DOI] [PubMed] [Google Scholar]
  • 31.Macmillan Cancer Support. Prehabilitation evidence and insight review . Macmillan Cancer Support; 2017. Cited 2022 May 3. Available from: https://www.macmillan.org.uk/_images/prehabilitation-evidence-and-insight-review_tcm9-335025.pdf.
  • 32.Macmillan Cancer Support, NIHR Cancer and Nutrition Collaboration, Royal College of Anaesthetists. Principles and guidance for prehabilitation within the management and support of people with cancer. Macmillan Cancer Support; 2019. Cited 2021 Oct 27. Available from: https://www.macmillan.org.uk/healthcare-professionals/news-and-resources/guides/principles-and-guidance-for-prehabilitation.
  • 33.Peters M, Godfrey C, McInerney P, Munn Z, Trico A, Khalil H. Chapter 11: Scoping Reviews. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. Cited 2022 Sep 28. Available from: https://wiki.jbi.global/display/MANUAL/Chapter+11%3A+Scoping+reviews.
  • 34.Gravier FE, Smondack P, Boujibar F, Prieur G, Medrinal C, Combret Y, et al. Prehabilitation sessions can be provided more frequently in a shortened regimen with similar or better efficacy in people with non-small cell lung cancer: a randomised trial. J Physiother. 2022;68(1):43–50. doi: 10.1016/j.jphys.2021.12.010. [DOI] [PubMed] [Google Scholar]
  • 35.Ferreira V, Minnella EM, Awasthi R, Gamsa A, Ferri L, Mulder D, et al. Multimodal prehabilitation for lung cancer surgery: a randomized controlled trial. Ann Thorac Surg. 2021;112(5):1600–1608. doi: 10.1016/j.athoracsur.2020.11.022. [DOI] [PubMed] [Google Scholar]
  • 36.Ferreira V, Lawson C, Carli F, Scheede-Bergdahl C, Chevalier S. Feasibility of a novel mixed-nutrient supplement in a multimodal prehabilitation intervention for lung cancer patients awaiting surgery: A randomized controlled pilot trial. Int J Surg. 2021;93:106079. doi: 10.1016/j.ijsu.2021.106079. [DOI] [PubMed] [Google Scholar]
  • 37.Sheill G, Guinan E, O’Neill L, Normand C, Doyle SL, Moore S, et al. Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial. BMC Cancer. 2020;20(1):321. doi: 10.1186/s12885-020-06795-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Quist M, Langer SW, Lillelund C, Winther L, Laursen JH, Christensen KB, et al. Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial. Lung Cancer. 2020;145:76–82. doi: 10.1016/j.lungcan.2020.05.003. [DOI] [PubMed] [Google Scholar]
  • 39.Barberan-Garcia A, Navarro-Ripoll R, Sánchez-Lorente D, Moisés-Lafuente J, Boada M, Messaggi-Sartor M, et al. Cost-effectiveness of a technology-supported multimodal prehabilitation program in moderate-to-high risk patients undergoing lung cancer resection: randomized controlled trial protocol. BMC Health Serv Res. 2020;20(1):207. doi: 10.1186/s12913-020-05078-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Laurent H, Aubreton S, Galvaing G, Pereira B, Merle P, Richard R, et al. Preoperative respiratory muscle endurance training improves ventilatory capacity and prevents pulmonary postoperative complications after lung surgery. Eur J Phys Rehabil Med. 2020;56(1). Cited 2022 Oct 17. Available from: https://www.minervamedica.it/index2.php?show=R33Y2020N01A0073. [DOI] [PubMed]
  • 41.Lai Y, Wang X, Zhou K, Su J, Che G. Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: a randomized trial. Ann Transl Med. 2019;7(20):544–544. doi: 10.21037/atm.2019.09.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bhatia C, Kayser B. Preoperative high-intensity interval training is effective and safe in deconditioned patients with lung cancer: a randomized clinical trial. J Rehabil Med. 2019;51(9):712–718. doi: 10.2340/16501977-2592. [DOI] [PubMed] [Google Scholar]
  • 43.Liu Z, Qiu T, Pei L, Zhang Y, Xu L, Cui Y, et al. Two-week multimodal prehabilitation program improves perioperative functional capability in patients undergoing thoracoscopic lobectomy for lung cancer: a randomized controlled trial. Anesth Analg. 2020;131(3):840–849. doi: 10.1213/ANE.0000000000004342. [DOI] [PubMed] [Google Scholar]
  • 44.Ulrich CM, Himbert C, Boucher K, Wetter DW, Hess R, Kim J, et al. Precision-Exercise-Prescription in patients with lung cancer undergoing surgery: rationale and design of the PEP study trial. BMJ Open. 2018;8(12):e024672. doi: 10.1136/bmjopen-2018-024672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Vanderbyl BL, Mayer MJ, Nash C, Tran AT, Windholz T, Swanson T, et al. A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer. Support Care Cancer. 2017;25(6):1749–1758. doi: 10.1007/s00520-017-3579-x. [DOI] [PubMed] [Google Scholar]
  • 46.Dhillon HM, Bell ML, van der Ploeg HP, Turner JD, Kabourakis M, Spencer L, et al. Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol. 2017;28(8):1889–1897. doi: 10.1093/annonc/mdx205. [DOI] [PubMed] [Google Scholar]
  • 47.Sebio García R, Yáñez-Brage MI, Giménez Moolhuyzen E, Salorio Riobo M, Lista Paz A, Borro Mate JM. Preoperative exercise training prevents functional decline after lung resection surgery: a randomized, single-blind controlled trial. Clin Rehabil. 2017;31(8):1057–1067. doi: 10.1177/0269215516684179. [DOI] [PubMed] [Google Scholar]
  • 48.Karenovics W, Licker M, Ellenberger C, Christodoulou M, Diaper J, Bhatia C, et al. Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled study†. Eur J Cardiothorac Surg. 2017;52(1):47–54. doi: 10.1093/ejcts/ezx030. [DOI] [PubMed] [Google Scholar]
  • 49.Licker M, Karenovics W, Diaper J, Frésard I, Triponez F, Ellenberger C, et al. Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery: a randomized controlled trial. J Thorac Oncol. 2017;12(2):323–333. doi: 10.1016/j.jtho.2016.09.125. [DOI] [PubMed] [Google Scholar]
  • 50.Kaya SO, Akcam TI, Ceylan KC, Samancılar O, Ozturk O, Usluer O. Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study. J Cardiothorac Surg. 2016;11(1):14. doi: 10.1186/s13019-016-0407-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Gravier FE, Bonnevie T, Boujibar F, Médrinal C, Prieur G, Combret Y, et al. Effect of prehabilitation on ventilatory efficiency in non–small cell lung cancer patients: a cohort study. J Thorac Cardiovasc Surg. 2019;157(6):2504–2512.e1. doi: 10.1016/j.jtcvs.2019.02.016. [DOI] [PubMed] [Google Scholar]
  • 52.Boujibar F, Bonnevie T, Debeaumont D, Bubenheim M, Cuvellier A, Peillon C, et al. Impact of prehabilitation on morbidity and mortality after pulmonary lobectomy by minimally invasive surgery: a cohort study. J Thorac Dis. 2018;10(4):2240–2248. doi: 10.21037/jtd.2018.03.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yao L, Chen H, Xue B. Application and practice of trimodal prehabilitation model in preoperative management of patients with lung cancer undergoing video-assisted thoracoscopic surgery. Front Surg. 2023;6(9):1047977. doi: 10.3389/fsurg.2022.1047977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Goldsmith I, Chesterfield-Thomas G, Toghill H. Pre-treatment optimization with pulmonary rehabilitation in lung cancer: making the inoperable patients operable. EClinicalMedicine. 2021;31:100663. doi: 10.1016/j.eclinm.2020.100663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Schmid S, Minnella EM, Pilon Y, Rokah M, Rayes R, Najmeh S, et al. Neoadjuvant prehabilitation therapy for locally advanced non–small-cell lung cancer: optimizing outcomes throughout the trajectory of care. Clin Lung Cancer. 2022;23(7):593–599. doi: 10.1016/j.cllc.2022.05.004. [DOI] [PubMed] [Google Scholar]
  • 56.Ferreira V, Lawson C, Gillis C, Scheede-Bergdahl C, Chevalier S, Carli F. Malnourished lung cancer patients have poor baseline functional capacity but show greatest improvements with multimodal prehabilitation. Nutr Clin Pract. 2021;36(5):1011–1019. doi: 10.1002/ncp.10655. [DOI] [PubMed] [Google Scholar]
  • 57.Bradley P, Merchant Z, Rowlinson-Groves K, Taylor M, Moore J, Evison M. Feasibility and outcomes of a real-world regional lung cancer prehabilitation programme in the UK. Br J Anaesth. 2022;S0007091222002951. [DOI] [PMC free article] [PubMed]
  • 58.Ricketts WM, Bollard K, Streets E, Hutton K, Hornby C, Lau K. Feasibility of setting up a pre-operative optimisation ‘pre-hab’ service for lung cancer surgery in the UK. Perioper Med. 2020;9(1):14. doi: 10.1186/s13741-020-00145-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Finley DJ, Fay KA, Batsis JA, Stevens CJ, Sacks OA, Darabos C, et al. A feasibility study of an unsupervised, pre‐operative exercise program for adults with lung cancer. Eur J Cancer Care (Engl). 2020;29(4). Cited 2023 Mar 8. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ecc.13254. [DOI] [PMC free article] [PubMed]
  • 60.Egegaard T, Rohold J, Lillelund C, Persson G, Quist M. Pre-radiotherapy daily exercise training in non-small cell lung cancer: a feasibility study. Rep Pract Oncol Radiother. 2019;24(4):375–382. doi: 10.1016/j.rpor.2019.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Collaço N, Henshall C, Belcher E, Canavan J, Merriman C, Mitchell J, et al. Patients’ and healthcare professionals’ views on a pre- and post-operative rehabilitation programme (SOLACE) for lung cancer: a qualitative study. J Clin Nurs. 2022;31(1–2):283–293. doi: 10.1111/jocn.15907. [DOI] [PubMed] [Google Scholar]
  • 62.Shukla A, Granger CL, Wright GM, Edbrooke L, Denehy L. Attitudes and perceptions to prehabilitation in lung cancer. Integr Cancer Ther. 2020;19:153473542092446. doi: 10.1177/1534735420924466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Finley DJ, Stevens CJ, Emond JA, Batsis JA, Fay KA, Darabos C, et al. Potential effectiveness of a surgeon-delivered exercise prescription and an activity tracker on pre-operative exercise adherence and aerobic capacity of lung cancer patients. Surg Oncol. 2021;37:101525. doi: 10.1016/j.suronc.2021.101525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Minnella EM, Baldini G, Quang ATL, Bessissow A, Spicer J, Carli F. Prehabilitation in thoracic cancer surgery: from research to standard of care. J Cardiothorac Vasc Anesth. 2021;35(11):3255–3264. doi: 10.1053/j.jvca.2021.02.049. [DOI] [PubMed] [Google Scholar]
  • 65.Cancer Research UK. Cancer Research UK. Lung cancer treatment statistics 2013–2014. 2013 2014. Cited 2022 Oct 17. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/diagnosis-and-treatment#heading-Three.
  • 66.Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):88. doi: 10.1186/s12913-017-2031-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Brennan J. Adjustment to cancer? coping or personal transition? Psychooncology. 2001;10(1):1–18. doi: 10.1002/1099-1611(200101/02)10:1<1::aid-pon484>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  • 68.Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;30:n2061. doi: 10.1136/bmj.n2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Lambaudie E, Bannier/Braticevic C, Villaron/Goetgheluck C, Zemmour C, Boher JM, Ben Soussan P, et al. TRAINING-Ovary 01 (connecTed pRehabiliAtIoN pelvIc caNcer surGery): multicenter randomized study comparing neoadjuvant chemotherapy for patients managed for ovarian cancer with or without a connected pre-habilitation program. Int J Gynecol Cancer. 2021;31(6):920–4. [DOI] [PubMed]
  • 70.Toohey K, Hunter M, McKinnon K, Casey T, Turner M, Taylor S, et al. A systematic review of multimodal prehabilitation in breast cancer. Breast Cancer Res Treat. 2023;197(1):1–37. doi: 10.1007/s10549-022-06759-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Bundred JR, Kamarajah SK, Hammond JS, Wilson CH, Prentis J, Pandanaboyana S. Prehabilitation prior to surgery for pancreatic cancer: a systematic review. Pancreatology. 2020;20(6):1243–1250. doi: 10.1016/j.pan.2020.07.411. [DOI] [PubMed] [Google Scholar]
  • 72.Dagorno C, Sommacale D, Laurent A, Attias A, Mongardon N, Levesque E, et al. Prehabilitation in hepato-pancreato-biliary surgery: a systematic review and meta-analysis. A necessary step forward evidence-based sample size calculation for future trials. J Visc Surg. 2022;159(5):362–72. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analysed during this study are included in this published article.


Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES